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 ABSTRACT 
	
Risk Factors and Outcomes of Bloodstream Infection 
 
Sainfer Elizabeth Aliyu  
 
This dissertation examines risk factors and outcomes associated with bloodstream 
infection (BSI). In Chapter One, the problems of BSI are introduced and their significance 
described. In Chapter Two, the results of a systematic review and meta-analysis synthesizing the 
prevalence of one of the most rapidly emerging causes of BSI among nursing home residents, 
multidrug resistant-gram negative bacteria are described. In Chapter Three, a retrospective 
cohort study identifying the prevalence and risk factors for BSI present on hospital admission 
(POA) is reported, including an assessment of antimicrobial resistance in isolates causing BSI-
POA by admission source (i.e. private homes, other hospitals and skilled nursing facilities). In 
Chapter Four, a retrospective cohort study explaining risks for hospital-associated infections 
(HAIs) among the BSI-POA cohort is described. Length of stay and mortality among patients 
with a BSI-POA who develop HAI and those who do not are reported. Finally, in Chapter Five, 
findings of the previous chapters are synthesized and the conclusion is provided including 
strengths, limitations and implications for policy and practice.
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Chapter One: Introduction  
In this Chapter, I introduce the challenges associated with risk factors and outcomes of 
bloodstream infection (BSI). First, I describe the theoretical framework underpinning my work. 
Second, I discuss the context of this problem. Third, I present information on the clinical 
importance of conducting research into these problems along with the gaps in the literature and 
how I propose to contribute to filling those gaps. Lastly, I describe the aims of my dissertation 
and outline how it is organized.  
Theoretical Framework  
The overarching framework is the epidemiologic triad of agent, host and environment, as 
adapted in Figure 1.1, which describes three categories of factors and their interrelationship that 
influence disease progression (Clark, 1954). This theoretical framework proposes that the 
presence of any disease requires an agent (i.e., a pathogen that causes the disease), a host (i.e., 
the susceptible individual who harbors the disease), and an environment (i.e., those external 
factors that permit disease transmission) (Centers for Disease Control and Prevention, 2015b). 
The framework is a well-established epidemiologic model that conceptualizes the infectious 
disease process and serves to guide research of the causal pathways of disease (Greenland, Gago-
Dominguez, & Castelao, 2004). Understanding the different aspects of the epidemiologic triangle 
can elucidate knowledge about the multifaceted disease process which occurs with BSI. 
Additionally, acting on any of the contributors can play a preventive role in the development of 
the disease (Centers for Disease Control and Prevention, 2015b). The framework underlying the 
studies is not included in the individual manuscripts but is described at the beginning of each 
chapter.  
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Problems  
1) Multidrug Resistant-Gram Negative Bacteria in Nursing Home Residents 
As one of the most rapidly emerging causes of BSI, multidrug resistant-gram negative 
bacteria (MDR-GNB) present a major complication when caring for vulnerable patients (Pop-
Vicas & Opal, 2014). These infections have been frequently documented among nursing home 
(NH) residents and are associated with increased mortality (Cerceo, Deitelzweig, Sherman, & 
Amin, 2016). Contributing factors to high rates of infection in this population include extensive 
use of antimicrobials, multiple comorbidities, use of devices such as urinary catheters, immune 
deficiencies and decreased mobility (Little, 2011; Lueangarun & Leelarasamee, 2012). NH 
residents with MDR-GNB have contributed to the influx of these infections in the hospital 
setting during care transitions (Boucher et al., 2009; Cerceo et al., 2016). Additionally, the 
growing problem of MDR-GNB has become a serious public health threat and development of 
novel antibiotics to treat MDR-GNB has slowed (Spellberg et al., 2008; Xu, Flavin, & Flavin, 
2014).  
Significance and Gap in the Literature  
Understanding Multidrug Resistant-Gram Negative Bacteria Among Nursing Home Residents 
Antimicrobial resistance, especially those caused by gram-negative bacteria is a 
challenging issue facing the medical community (Xu et al., 2014). It has been estimated that by 
2050, antimicrobial resistance will kill 10 million people annually (instead of the current 700,000 
people annually) at a cumulative cost of $100 trillion United States dollars if we do not find 
solutions now to slow the rate of antimicrobial resistance (O'Neil Jim, 2014). Of equal concern is 
the steady increase of MDR-GNB worldwide which makes ideal healthcare-associated pathogens 
because they often survive for long periods and can be transiently transferred between patients 
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by healthcare workers (Arias & Murray, 2009; Morgan et al., 2010). NH residents may be more 
at risk to harbor MDR-GNB which may cause serious infections, re-admissions, increased length 
of stay, mortality and cost (Lim et al., 2014; Montoya & Mody, 2011). Therefore, infection 
management in this population has important implications for providing high-quality care and 
minimizing the imminent concern posed by MDR-GNB (Giamarellou & Poulakou, 2009).  
From the initial survey of the literature, we concluded that because of the paucity of 
evidence regarding MDR-GNB in NH residents, further research is needed to measure the 
prevalence and characterize the population that is at high risk for harboring this infection. A 
systematic review and meta-analysis, presented in Chapter Two, summarizes published studies in 
this area which could inform healthcare policy and infection prevention and control measures.  
2) Bloodstream Infection Present on Hospital Admission 
Bloodstream infections (BSIs) are ranked among the most serious infections in the 
healthcare setting (Marchaim et al., 2012). In addition, the prevalence of BSI present on hospital 
admission (POA) has increased steadily over time and is an important cause of mortality and 
morbidity. Traditionally BSI-POA have been classified as community-associated (CA) 
infections. However, due to an increase in the number of outpatient treatment centers and 
patients who frequently interact with the healthcare system, some of the CA-BSI infections are 
now recognized as healthcare-associated (HA)-BSI (Lenz et al., 2012).  
The overall population-based incidence of BSI-POA differs considerably among regions 
with estimates ranging from 81.6 to 145 per 100,000 person years (Laupland et al., 2007; 
Sogaard, Norgaard, Dethlefsen, & Schonheyder, 2011; Uslan et al., 2007). These variations are 
due in part to microbiologic culturing practices, population demographics and exposure to risk 
factors (Laupland, 2013). Additionally, BSI-POA may often be caused by antibiotic-resistant 
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organisms, creating a greater risk for morbidity and mortality (Orsini et al., 2012). 
Significance and Gap in the Literature  
Understanding risk for Bloodstream Infection Present on Hospital Admission 
Understanding the characteristics of CA-BSI and HA-BSI may be relevant in the 
selection of antibiotics or other interventions (Lenz et al., 2012; McKay & Bamford, 2015). 
Compared to patients with CA-BSI (e.g., those from private homes), patients with HA-BSI (e.g., 
those from nursing homes or other healthcare facilities) have environmental risks such as 
exposure to invasive devices, medications and facilty. Hence, specific interventions should be 
implemetned based on the type of infection. 
Identifying predictors for BSI-POA could help clinicians develop patient profiles and 
create order sets in the electronic health record, thereby facilitating best practices and better 
patient outcomes. Likewise, information about antibiotic-resistant BSI-POA could diminish the 
misuse of antibiotics, which potentiates the emergence of resistant organisms and unnecessary 
adverse drug effects (Chen et al., 2013). To address these gaps, a secondary analysis using a 
large dataset from three hospitals in New York City, between 2006-2014 was undertaken to 
examine risk factors of BSI-POA and antimicrobial resistance in isolates. Methods and findings 
are presented in Chapter Three. 
3) Risk for Developing Hospital-Associated Infection Among Patients Admitted with a 
Bloodstream Infection  
Hospital-associated infections (HAIs) occur > 48 hours after hospitalization (Centers for 
Disease Control and Prevention, 2016b) and are associated with increased use of resources, 
higher mortality rate and longer lengths of stay (Barnett et al., 2013; Rahmqvist, Samuelsson, 
Bastami, & Rutberg, 2016; Sydnor & Perl, 2011). An estimated 700,000 HAIs occur annually, 
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affecting one in 25 hospitalized patients. Each year, about 75,000 patients with HAI die during 
their hospitalizations, making HAI the tenth leading cause of death in the United States (Centers 
for Disease Control and Prevention, 2016b). Furthermore HAI is costly, with annual 
expenditures estimated to be $9.8 billion in 2012 United States dollars (Zimlichman et al., 2013).   
Because BSI-POA is associated with a high burden of illness (Laupland & Church, 2014; 
Lenz et al., 2012), patients with this condition generally have longer hospitalizations and more 
interactions with hospital staff, thereby increasing their risk for HAI.  
Significance and Gap in the Literature 
Understanding the Relationship Between Bloodstream Infection Present on Hospital Admission 
and Risk for Developing Subsequent Hospital-Associated Infection   
Great efforts have been made to reduce HAI in the past decade, but it remains a common 
complication in hospitalized patients. While the association between BSI-POA and development 
of subsequent HAI has been reported (Otter & French, 2011), the evidence base examining this 
relationship has not been extensive. The incidence of HAI among BSI-POA cases and data 
regarding length of hospital stay and mortality are unknown. Such information is useful to help 
set goals necessary to reduce infection. Similarly, most studies about HAI focus on certain 
groups of patients, for instance those in the intensive care unit, burn unit or neonatal intensive 
care unit (Coban, 2012; Dasgupta, Das, Chawan, & Hazra, 2015; Polin, Denson, & Brady, 2012; 
Sadowska-Krawczenko, Jankowska, & Kurylak, 2012; van Vught et al., 2016). Risks for HAI 
vary by patient characteristics, use of invasive devices, severity of illness and the treatment 
provided (Agodi et al., 2013), so it is important to examine attributes among other types of 
compromised patients such as those admitted with a BSI.  
In light of the preventability of many HAIs, obtaining greater understanding of risks for 
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developing HAI is crucial to tailor surveillance and implement appropriate protocols. If hospitals 
are to reduce length of stay and morality ascribable to HAI, additional research on the current 
state of the science surrounding these types of infections is warranted. A secondary analysis 
using a large dataset from three hospitals in New York City, between 2006-2014 was conducted 
to generate new evidence. Methods and findings are presented in Chapter Four.  
Aims and Organization  
 The five aims of this dissertation were addressed in three separate studies summarized in 
Table 1.1, each of which has been accepted for publication, currently under review or is being 
prepared for publication according to the specific requirements of the intended journals. The first 
manuscript (Chapter Two: Multidrug resistant-gram negative bacteria in nursing home residents, 
is a systematic review and meta-analysis) is accepted for publication in the American Journal of 
Infection Control. The second manuscript (Chapter Three: Risk factors for bloodstream infection 
present on hospital admission) is currently under review with the Journal of Infection 
Prevention. The third manuscript (Chapter Four: Risk for developing hospital-associated 
infection among patients with bloodstream infection present on hospital admission) is in 
preparation for submission. Chapter Five summarizes the findings for all three studies and 







  7 





2 Prevalence of multidrug 
resistant-gram negative 
bacteria among nursing 
home residents: A systematic 
review and meta-analysis 
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of the prevalence of multidrug resistant-gram 
negative bacteria among nursing home 
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infection present on hospital 
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2) Measure prevalence and characteristics of 
patients with bloodstream infection present on 
hospital admission (BSI-POA) 
3) Compare antimicrobial resistance in 
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4 Risk for hospital-associated 
infection among patients 
with bloodstream infection 
present on hospital 
admission 
4) Examine the relationship between being 
admitted with BSI and developing subsequent 
hospital-associated infection (HAI)  
5) Compare hospital length of stay and 
mortality between patients with a BSI-POA 
who develop HAI and those who do not  
Note: Chapters Three and Four pertain to secondary analysis of data from a larger NIH-funded 
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Figure 1.1 Adaptation of the Epidemiologic Triad Framework* to Study Risk Factors and 
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Chapter Two: Prevalence of Multidrug Resistant-Gram Negative Bacteria Among Nursing 
Home Residents: A Systematic Review and Meta-Analysis 
This manuscript is accepted for publication in the American Journal of Infection Control, 
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*Comorbid conditions: Conditions vary by studies 
BSI = Bloodstream infection  
MDR-GNB = Multidrug resistant-gram negative bacteria 
NH = Nursing home 
  
Adapted from Clark, E. G. (1954). Natural history of syphilis and levels of prevention. Br J 
Vener Dis, 30(4), 191-197.  
 
            Chapter Two, to review prevalence of multidrug resistant-gram negative bacteria 
(MDR-GNB) among nursing home (NH) residents: A systematic review and meta-analysis 
assessed the interaction between the agent, host and the environment using the epidemiologic 
triad, as adapted in Figure 2.1. The MDR-GNB associated with bloodstream infection were 
considered as the agent category. Characteristics such as age, gender and comorbid 
conditions were considered as the host category. NH stay and invasive devices were 
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Abstract   
Multidrug resistant-gram negative bacteria (MDR-GNB) are associated with an 
increasing proportion of infections among nursing home (NH) residents. The objective of this 
systematic review and meta-analysis was to critically review evidence of the prevalence of 
MDR-GNB among NH residents. Following Meta-Analysis of Observational Studies in 
Epidemiology guidelines, a systematic review of literature for years 2005-2016 using multiple 
databases was conducted. Study quality, appraised by 2 reviewers, used Downs and Black risk of 
bias criteria. Studies reporting prevalence of MDR-GNB colonization were pooled using a 
random effects meta-analysis model. Heterogeneity was assessed using Cochran Q and I2 
statistics. Of 327 articles, 12 met criteria for review; of these, 8 met criteria for meta-analysis. E. 
coli accounted for the largest proportion of isolates. Reported MDR-GNB colonization 
prevalence ranged from 11.2% to 59.1%. Pooled prevalence for MDR-GNB colonization, 
representing data from 2,720 NH residents, was 27% (95% confidence interval (CI): 15.2 - 
44.1%), with heterogeneity (Q = 405.6, p = 0.01; I2 = 98.3). Two studies reported MDR-GNB 
infection rates of 10.9% and 62.7%. Our findings suggest a high prevalence of MDR-GNB 
colonization among NH residents, emphasizing the need to enhance policies for infection control 
and prevention in NHs.  
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Introduction  
Multidrug resistant-gram negative bacteria (MDR-GNB) are an increasingly prevalent 
public health concern (Cerceo et al., 2016; Kallen & Srinivasan, 2010). Infections due to MDR-
GNB are common among nursing home (NH) residents and are associated with increased 
morbidity, mortality and hospitalization (Cerceo et al., 2016; Kallen & Srinivasan, 2010). MDR-
GNB present difficulties with effective treatment as there are limited availability of viable 
therapeutic options (Kallen & Srinivasan, 2010). The Centers for Disease Control and Prevention 
(CDC) reports that MDR-GNB such as carbapenem-resistant Enterobacteriaceae (CRE) and 
Acinetobacter spp in particular are increasing in prevalence (Centers for Disease Control and 
Prevention, 2015a), a problem compounded by the fact that the research and development 
pipeline for novel antimocrobial agents to treat MDR-GNB has slowed (Spellberg et al., 2008; 
Xu et al., 2014).  
Factors associated with the rising numbers of MDR-GNB among NH residents include 
extensive antimicrobial exposure and frequent hospitalization (Kahvecioglu et al., 2014; Pop-
Vicas, Strom, Stanley, & D'Agata, 2008). Elder NH residents are especially susceptible to 
infections due to multiple comorbidities, advanced age and immune dysfunction (Little, 2011; 
Lueangarun & Leelarasamee, 2012). Residence in a NH is considered a risk factor for MDR-
GNB and frequent transfer from NH to acute care contributes to the influx of pathogens into the 
hospital setting (Cerceo et al., 2016). Prevention and management of MDR-GNB in NHs are 
complicated and require extensive infection control resources due to challenges common to this 
setting such as understaffing, fewer resources, insufficient training and inadequate surveillance 
(Lubart et al., 2011; Mody et al., 2011). Understanding the dynamics of MDR-GNB transmission 
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and the mechanism of acquisition maybe helpful to identify effective infection control strategies 
specific to NHs.  
The epidemiology of MDR-GNB among NH residents is poorly understood. To our 
knowledge, a paucity of studies has examined MDR-GNB in this population. Most of the 
available studies on MDR-GNB were conducted in acute care setting and were limited to a 
particular species rather than assessing the overall disease burden. While systematic reviews of 
MDR-GNB have been conducted in acute care settings (Raman, Avendano, Berger, & Menon, 
2015; Zaky, Zeliadt, & Treggiari, 2015), we found no systematic reviews or meta-analyses 
which examine MDR-GNB among NH residents. Given that NH residents have a greater risk for 
acquiring MDR-GNB, prolonged hospitalization and higher mortality rates (Kahvecioglu et al., 
2014; Pop-Vicas, Strom, et al., 2008), it is important to gain insights that could inform the 
control and prevent the emergence of these infections. Therefore, the objective of this systematic 
review and meta-analysis was to critically review evidence of the prevalence of MDR-GNB 
among NH residents. 
Methods 
Search Strategy  
 We followed the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) 
guidelines to ensure a standard method for transparent reporting of systematic reviews and meta-
analysis of observational studies (Stroup et al., 2000). With consultation from a library 
information specialist, searches were conducted in the following electronic, scientific literature 
databases: Ovid Medline, EBSCO, Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), Web of Science, and Cochrane Central Register of Clinical Trials. The search 
strategy was designed to identify articles that focused on MDR-GNB in NH residents. Synonyms 
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and related phrases of the following key words were used in various combinations, including: 
“gram-negative bacterial infection,” “multidrug-resistant gram-negative bacteria,” “multidrug-
resistant gram-negative bloodstream infection,” “nursing home residents,” “nursing homes” and 
“long-term care facilities”.  
Selection Criteria  
Studies were included if 1) the primary outcome measures were MDR-GNB colonization 
or infection rates, distribution of MDR-GNB isolates and mortality rates among adult NH 
residents or patients admitted to an acute care setting from a NH with an infection caused by 
MDR-GNB and 2) were published between January1, 2005 and February 28, 2016 in English in 
a peer-reviewed, indexed journal. This time frame was chosen because we were interested in 
relatively recent data on MDR-GNB. We then conducted a hand search of reference lists of 
reviewed articles to ensure that all relevant studies were identified. Excluded were editorials, 
commentaries, and pediatric studies. Studies that examined MDR-GNB colonization were 
selected for meta-analysis. 
Two reviewers (SA and AS) assessed study eligibility. First, SA independently screened 
abstracts and final articles for which AS reviewed and confirmed eligibility. Differences in 
eligibility assessments were resolved by discussion and consensus among all authors. 
Study Selection  
 Figure 2.2 provides details of the literature search process. The electronic database 
yielded 453 articles; after removing duplicates, 327 were screened for eligibility. Of these, 296 
articles were excluded based on title and abstract screening. This resulted in retrieval of 31 full-
text articles as potentially eligible. After detailed examination, 20 additional articles were 
excluded because their outcome did not include MDR-GNB. One additional study was identified 
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from the reference list of reviewed articles resulting in 12 articles.  
Data Extraction 
Data were extracted by two reviewers (SA and AS). The following variables were 
recorded for each study: author; year and study location; study design; sample and setting; site of 
colonization; prevalence of colonization and infection rates and percentage of organism for 
MDR-GNB. Among the studies that reported infection and colonization rates, samples collected 
from blood, sputum and urine were classified as infection and samples collected from rectal, 
nasal, oropharyngeal, skin, throat, wounds, and inguinal swabs were classified as colonization. 
One study (Choi et al., 2012) reported sputum and urine as both infection and colonization. 
Assessment of Methodological Quality  
The 12 studies that met criteria for review were appraised for quality using the Downs 
and Black quality appraisal checklist, the instrument has high reported internal consistency 
reliability (Kuder-Richardson Formula 20, 0.89), good test-retest reliability (r = 0.88) and 
acceptable inter-rater reliability (r = 0.75) (Downs & Black, 1998). A modified instrument 
containing 20 items specific to observational studies (LaCross, Groff, & Smaldone, 2015; 
Usinger, Gola, Weis, & Smaldone, 2016) was utilized for quality appraisal. Scoring was as 
follows, (reporting, 8 items, with 1 item accounting for 2 points [9 points]; external validity, 3 
items [3 points]; internal validity-bias, 4 items [4 points]; internal validity-confounding, 4 items 
[4 points] and power, 1 item [1 point] with a maximum possible score of 21 points. Two 
reviewers (SA and AS) independently appraised each study; where reviewers disagreed, 
resolution was achieved through consensus.  
Quantitative Synthesis 
 Studies that reported MDR-GNB isolates by species were summed and presented as 
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percentages. One study (Marchaim et al., 2012) was excluded because only broader categories, 
extended-spectrum beta-lactamases (ESBL) and CRE, were reported rather than specific species. 
Studies reporting the prevalence of MDR-GNB colonization were included in a meta-
analysis. A pooled prevalence of MDR-GNB colonization was estimated using a random effects 
meta-analysis model. Heterogeneity was assessed using Cochran Q and I2 statistics with results 
presented as a forest plot. Sensitivity analyses were conducted to examine the effect of potential 
sources of heterogeneity across studies (Thompson & Higgins, 2002). To assess the potential for 
publication bias, we performed Rosenthal’s fail-safe N test to estimate the number of missing 
studies that would need to be added to the meta-analysis for the pooled effect to no longer be 
significant (Rothstein HR 2005). Data were analyzed using Comprehensive Meta-Analysis 
statistical software (Bio- stat, Inc., Englewood, NJ). 
Results  
Characteristics of Studies  
Table 2.2 details characteristics of the included studies. There was no standard definition 
for MDR-GNB across studies (Table 2.2). Study designs included 4 prospective (Choi et al., 
2012; D'Agata, Habtemariam, & Mitchell, 2015; Mitchell et al., 2014; O'Fallon, Gautam, & 
D'Agata, 2009), 3 retrospective (Marchaim et al., 2012; O'Fallon, Pop-Vicas, & D'Agata, 2009; 
Venkatachalam et al., 2014), 1 case-control (Pop-Vicas, Tacconelli, Gravenstein, Lu, & D'Agata, 
2009) and 4 cross sectional (Gruber et al., 2013; Hogardt et al., 2015; March et al., 2014; Pop-
Vicas, Mitchell, Kandel, Schreiber, & D'Agata, 2008). Sample sizes ranged from 51 
(Venkatachalam et al., 2014) to 1221 (Marchaim et al., 2012) participants. Overall, the majority 
of studies (n = 8) included more than one NH (Choi et al., 2012; D'Agata et al., 2015; Gruber et 
al., 2013; Hogardt et al., 2015; March et al., 2014; Marchaim et al., 2012; Mitchell et al., 2014; 
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Venkatachalam et al., 2014). Eight studies included only patients who resided in NHs (D'Agata 
et al., 2015; Gruber et al., 2013; Hogardt et al., 2015; Mitchell et al., 2014; O'Fallon, Gautam, et 
al., 2009; O'Fallon, Pop-Vicas, et al., 2009; Pop-Vicas, Mitchell, et al., 2008; Pop-Vicas et al., 
2009) and 4 included NH residents along with other patients (Choi et al., 2012; March et al., 
2014; Marchaim et al., 2012; Venkatachalam et al., 2014). Of the studies that reported follow up, 
follow up periods ranged from 6 months (Choi et al., 2012) to 1 year (D'Agata et al., 2015; 
Mitchell et al., 2014). The majority of studies were conducted in the United States (D'Agata et 
al., 2015; Marchaim et al., 2012; Mitchell et al., 2014; O'Fallon, Gautam, et al., 2009; O'Fallon, 
Pop-Vicas, et al., 2009; Pop-Vicas, Mitchell, et al., 2008; Pop-Vicas et al., 2009); the remaining 
were conducted in Korea (Choi et al., 2012), Italy (March et al., 2014), Singapore 
(Venkatachalam et al., 2014) and Germany (Gruber et al., 2013; Hogardt et al., 2015). 
Methodological Quality of studies 
 Figure 2.3 summarizes the quality appraisals by category. Quality of the studies varied, 
with quality scores ranging from 9 points (D'Agata et al., 2015) to 20 points (Hogardt et al., 
2015). Five studies demonstrated threats to external validity (D'Agata et al., 2015; Gruber et al., 
2013; O'Fallon, Gautam, et al., 2009; Pop-Vicas, Mitchell, et al., 2008; Venkatachalam et al., 
2014) by failing to fully describe their study sample and the facilities where subjects received 
care. In addition, studies demonstrated threats to internal validity. For example, 3 studies failed 
to adjust for length of follow-up of participants (Marchaim et al., 2012; O'Fallon, Pop-Vicas, et 
al., 2009; Pop-Vicas et al., 2009) in their statistical analyses and only 4 studies adjusted 
adequately for confounding (Hogardt et al., 2015; Mitchell et al., 2014; Pop-Vicas et al., 2009; 
Venkatachalam et al., 2014). Three studies adjusted for confounding in their analyses using 
multivariate models (Hogardt et al., 2015; Mitchell et al., 2014; Venkatachalam et al., 2014) and 
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1 study controlled for confounders by matching (Pop-Vicas et al., 2009). The appraisal of power 
was applied to all study designs except cross sectional prevalence studies; however, no studies 
reported scores in this domain. Overall, studies were more successful in meeting the criteria for 
reporting and internal validity.  
Outcomes 
 The prevalence of MDR-GNB colonization among study samples ranged from 11.2% 
(Gruber et al., 2013) to 59.1% (Marchaim et al., 2012). Nine of the 12 studies identified specific 
factors previously shown to be associated with increased MDR-GNB colonization risk including 
advanced age, gender, comorbid chronic diseases, history of recurrent hospitalization, increased 
interaction with healthcare workers, frequent antimicrobial exposure, delayed initiation of 
effective antibiotic therapy, presence of medical devices, decreased functional status, advanced 
dementia, non-ambulatory status, fecal incontinence, severe sepsis on present-on-admission and 
residency in a long-term care facility (Choi et al., 2012; D'Agata et al., 2015; Gruber et al., 2013; 
Hogardt et al., 2015; March et al., 2014; O'Fallon, Gautam, et al., 2009; Pop-Vicas, Mitchell, et 
al., 2008; Pop-Vicas et al., 2009; Venkatachalam et al., 2014). Two studies reported MDR-GNB 
infection rates of 10.9% (Choi et al., 2012) and 62.7% (Venkatachalam et al., 2014). The 
proportion of MDR-GNB isolates by species is summarized in Figure 2.4, with the exception of 
the study in which species were not reported (Marchaim et al., 2012). E. coli accounted for the 
largest proportion of isolates. The most common site of colonization was rectal, followed by 
nasal, sputum, urinary tract and wound.   
Meta-Analysis 
Of the 12 studies that examined the prevalence of MDR-GNB among NH residents, 8 
examined MDR-GNB colonization and were therefore eligible for meta-analysis (Choi et al., 
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2012; D'Agata et al., 2015; Gruber et al., 2013; Hogardt et al., 2015; Marchaim et al., 2012; 
Mitchell et al., 2014; O'Fallon, Gautam, et al., 2009; Pop-Vicas, Mitchell, et al., 2008). Figure 
2.5 represents data from 2,720 NH residents. Using a random effects model, the pooled MDR-
GNB colonization prevalence was 27% (95% confidence interval (CI): 15.2 - 44.1). 
Heterogeneity between and within studies was greater than expected by chance alone (Q = 405.6, 
p = 0.01) with the majority of the variability attributed to differences between studies (I2 = 98.3). 
Figure 2.6 presents findings from the sensitivity analysis that examined possible contributors to 
heterogeneity, which showed that percent colonization was significantly higher in studies 
conducted in U.S. (38%) compared to Korea and Germany (14%). However, there were no 
significant differences in reported colonization based on study design, year of study publication, 
or culture site. Regarding potential publication bias, the result of Rosenthal’s fail-safe N test 
indicates that 287 additional studies would need to be added to significantly alter the pooled 
prevalence finding.  
Discussion  
 To our knowledge, this is the first systematic review and meta-analysis to estimate the 
prevalence of MDR-GNB colonization among NH residents. Although study duration, study 
location and sample size varied considerably among studies and might have contributed to 
differences between groups, the review provides important insights and meaningful themes.  
First, a pooled estimate of 27% MDR-GNB colonization among NHs residents is 
concerning. NHs deliver longer term care which may involve more interaction among residents 
and potential opportunities for patient-to-patient and/or patient-to-staff contact and microbial 
transmission. While contact precaution measures exist, cross-transmission of organisms are 
common between residents in shared spaces or via healthcare workers (Mody, Bradley, & 
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Huang, 2013). There is a wide variation in isolation practices for colonized infections across 
NHs (Cohen. et al., 2015), so more standardized NH-specific policies may be an important step 
for detecting and controlling MDR-GNB (Mattner et al., 2012). 
Second, two studies reported MDR-GNB infection rates among patients admitted from a 
NH to the hospital. One study was conducted over 3-months and reported infection rate to be 
10.9% (Choi et al., 2012). Another study conducted over 31-months reported an infection rate of 
62.7%. The researchers suggested that this rate is likely attributable to acquisition and 
colonization in the NH that presents later as clinical infection (Venkatachalam et al., 2014). 
Since infection represents the tip of the iceberg for colonization, these results are consistent with 
other literature suggesting that rates of MDR-GNB are high in NHs (Cassone & Mody, 2015; 
Cerceo et al., 2016). Hence, when a patient is admitted from a NH to the hospital, surveillance 
for colonization may be indicated.  
Third, 3 studies reported mortality associated with infections among NH residents 
(Mitchell et al., 2014; O'Fallon, Pop-Vicas, et al., 2009; Venkatachalam et al., 2014). We were 
unable to find detailed information regarding MDR-GNB and mortality among NH residents, 
because NH residents with serious infections are transferred to acute care. Despite this, data 
show that NH residents represent a large reservoir of MDR-GNB (Pop-Vicas, Strom, et al., 
2008) and these organisms are associated with a high severity of illness (Harris, Paterson, & 
Rogers, 2015), therefore it is important to understand their impact on mortality.  
New efforts are underway to address issues relating to MDR-GNB. In 2015 the United 
States National Strategy for Combating Antibiotic Resistant Bacteria unveiled a public health 
action plan that highlights key areas including strengthening antibiotic stewardship, regulatory 
mandates and economic incentives (White House, 2015). In addition, the Infectious Diseases 
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Society of America identified seven drugs for treatment of MDR-GNB infections in their effort 
to support initiatives concerning antimicrobial resistance. Although promising, these drugs will 
only target ESBL, P. aeruginosa and A. baumannii infections. Moreover, drug development 
remains alarmingly slow; only 2 new antibiotics (telavancin and ceftaroline fosamil) have been 
approved since the Infectious Diseases Society of America 2009 pipeline status report with 
activity against MDR-GNB (Boucher et al., 2013). Advancing a sustainable solution to the 
MDR-GNB crisis requires constant surveillance, enhanced NH policies and practices and 
continued progress in research and development. 
Limitations 
This review was limited to studies published in English language and in peer-reviewed 
journals after 2005. Limiting our search, however, is justified given the emergence of MDR-
GNB in recent years. Additionally, publication bias must be considered because results of 
negative findings may not have been published. Limitations of the studies included variations in 
how infection and colonization of MDR-GNB were defined. Further, half of the studies reviewed 
were co-authored by the same research team.  
Conclusion 
Prevalence of MDR-GNB among NH residents is a growing area of research, but there 
are important gaps to be filled. Based on this review, we conclude: 1) More research is warranted 
on the epidemiology of MDR-GNB including identifying risk factors that influence colonization, 
infection and mortality among NHs residents. 2) For residents with suspected MDR-GNB 
colonization, targeted surveillance and reporting are needed to establish a comprehensive 
understanding of the burden associated with MDR-GNB. 3) Since residents of NHs are a high-
risk population for colonization with antibiotic-resistant bacteria (Cerceo et al., 2016), screening 
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on hospital admission may be indicated to identify colonized/infected patients and, when 
indicated, aid in the selection of appropriate antimicrobial therapy. 4) Finally, it is essential to 
reexamine the efficacy of infection control practices in NHs and implement policies specific to 
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Table 2.1 Medline Search Strategy Code 
 
Database(s): January1, 2005 to February 28, 2016 
Ovid Medline 
EBSCO 
Cumulative Index of Nursing and Allied Health Literature (CINAHL) 
Web of Science 
1. gram-negative bacterial infection.mp. 
2. multi drug resistant gram negative infections.mp. 
3. multi drug resistant gram negative organisms.mp. 
4. multidrug-resistant gram-negative bacteria.mp. 
5. 1 or 2 or 3 or 4 
6. nursing homes/or long term care/ 
7. long term care facility.mp. 
8. nursing home facilities.mp. 
9. nursing home residents.mp. 
10. 6 or 7 or 8 or 9 
11. 5 and 10 


































55 residents age 50 
years and older 









Bacteria resistant or intermediately 
susceptible to at least 3 of the following: 
ampicillin-sulbactam or piperacillin-
tazobactam; ceftraxone or ceftazidime; 
fluoroquinolones (ciprofloxacin or 
levofloxacin); imipenem or meropenem; 








152 residents 65 
years and older 







Not reported 9 
 
Bacteria resistant to at least 3 of the 
following: ciprofloxacin; extended- 
spectrum penicillins (ampicillin/sulbactam 
or piperacillin/ tazobactam); meropenem, 
gentamicin; and third-generation 
cephalosporins (ceftazidime or 
ceftriaxone) 















Not reported 14 Bacteria resistant to extended-spectrum 
beta-lactamase (ESBL) producing 
Enterobacteriaceae 













17.8% Not reported 20 Resistant to 3 antibiotics groups: 
ureidopenicillins; third- and/or fourth-
generation cephalosporins and 
fluoroquinolones) represented by 
piperacillin, cefotaxime and/or ceftazidime 
and ciprofloxacin 



















Not reported Not reported 16 
 
Bacteria resistant to ESBL producing 
enterobacteriaceae: escherichia coli; 








1221 residents from 
LTCFs from 3 
health systems  
Cultures were 




Not reported 16 ESBL-producing enterobacteriaceae 
(klebsiella species and escherichia coli); 
carbapenem-resistant enterobacteriaceae 
(klebsiella spp, e coli, and enterobacter 
spp); acinetobacter baumannii and 
pseudomonas aeruginosa (regardless of 










362 residents age 65 








Not reported 19 Resistant to 3 or more of the following: 
ampicillin-sulbactam or piperacillin-
tazobactam combination drugs; 
ceftriaxone or ceftazidime; ciprofloxacin; 










15.6% Not reported 16 Resistance or intermediate susceptibility to 
3 of the following: ampicillin-sulbactam or 
piperacillin-tazobactam; meropenem; 






































51.2% Not reported 15 
 
Bacteria resistant or intermediately 
susceptible to at least 3 of the following: 
ampicillin/sulbactam; cephalosporins 
(cefazolin, ceftriaxone, or ceftazidime); 
ciprofloxacin; gentamicin; 









60 residents age 65 
years and older 
from a LTCF 
Blood cultures Not reported 
 
   Not reported 
                                                                                                                                                                                   
19 Resistant or intermediately susceptible to 3 
or more of the following antimicrobials:
extended-spectrum penicillins (ampicillin-
sulbactam or piperacillin-tazobactam); 
carbapenems (imipenem or meropenem); 
ceftazidime; fluoroquinolones 
(ciprofloxacin or levofloxacin); and 
aminoglycosides (gentamicin, tobramycin, 
or amikacin) 
Venkatac-






51 residents age 16 
years and older 
from LTCFs 
 







Bacteria resistant to all antimicrobial 
agents in 3 or more antibiotic classes were 
defined as MDR 
a MDR-GNB = Multidrug resistant-gram negative bacteria  
b LTCF = Long-term care facility 
c NH = Nursing home 
d Maximum quality score = 21 points
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Articles identified from databases [N = 453] 
 
Duplicates removed [N = 126] 
Articles excluded [N = 296] 
1.  
Titles and abstracts screened [N = 327] 
 
Full-text screened for eligibility [N =31] 
Articles identified through the reference 
lists of reviewed articles 
 [N =1] 
Full-text articles not meeting inclusion 
criteria [N = 20] 
3.  
Studies included for final synthesis [N = 12] 
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Figure 2.5 Forest Plot of Multidrug Resistant-Gram Negative Bacteria Colonization 
Among Nursing Home Residents 
 
Squares represent effect sizes of individual studies, with extended lines denoting 95% confidence intervals. Sizes of 
squares indicate the weight of each study based on sample size using a random effect meta-analytic model. The 
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Figure 2.6 Heterogeneity Subgroup Analysis for Multidrug Resistant-Gram Negative 
Bacteria Colonization Meta-Analysis 
 
Variable Number of studies  % Colonization 
(95% CI)     
Study location   
     Non-USA 3 0.14 (0.06-0.30) 
     USA 5 0.38 (0.23-0.55) 
Study design   
     Cross sectional 3 0.23 (0.08-0.51) 
     Prospective 4 0.24 (0.10-0.48) 
     Retrospective 1 0.59 (0.15-0.92) 
Year of study   
     During or before   
     2012 
4 0.23 (0.09-0.47) 
     After 2012 4 0.32 (0.13-0.60) 
Culture site   
     1 - 2 sites 4 0.32 (0.12-0.62) 
     3 or more sites 4 0.23 (0.08-0.50) 
  P <0.05, % colonization significantly higher in studies conducted in U.S.  
  CI = Confidence Interval 
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Chapter Three: Prevalence and Risk Factors for Bloodstream Infection Present on 
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BSI-POA = Bloodstream infection present on hospital admission 
*Comorbid conditions = Renal failure, malignancies, chronic dermatitis, burns and diabetes mellitus 
*Admission source = Skilled nursing facility, private home, hospital transfer 
 
Adapted from Clark, E. G. (1954). Natural history of syphilis and levels of prevention. Br J 
Vener Dis, 30(4), 191-197. 
 
Chapter Three, to describe the risk factors for bloodstream infection present on hospital 
admission (BSI-POA), assessed the interaction between the agent, host and the environment 
using the epidemiologic triad, as adapted in Figure 3.1. Organisms associated with BSI-POA, 
including Staphylococcus aureus, Pseudomonas aeruginosa, Enteroccous faecalis/faecium, 
Streptococcus pneumoniae, Klebsiella pneumoniae, and Acinetobacter baumannii, were placed 
in the agent category. Risk factors for BSI-POA, including age, gender, comorbid conditions and 
Charlson Comorbidity Index (CCI) were placed in the host category. Admission source, for 
instance, (admission from a skilled nursing facility, private home or other hospital) was placed in 
the environment category.  
  Agent 





     
   Host 





*Admission source  
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Abstract 
Bloodstream infection present on hospital admission (BSI-POA) is a major cause of morbidity 
and mortality. The purpose of this study was to measure prevalence and describe the risk factors 
of patients with BSI-POA, and determine the prevalence of resistance in isolates by admission 
source. We conducted a retrospective cohort study of patients discharged from three hospitals in 
New York City between 2006 and 2014. BSI-POA was defined as BSI diagnosed within 48 
hours of hospitalization. Patient data were identified using the electronic medical records. We 
identified 5,307 BSI-POA cases. The prevalence for BSI-POA was 5307/315,010 discharges 
(1.7%). The odds of being admitted with BSI-POA were greatest among patients admitted with 
renal failure, chronic dermatitis and malignancies. Odds ratios and 95% confidence intervals 
were 2.63 (2.47-2.81), 2.21 (2.03-2.41) and 1.49 (1.36-1.61) respectively. The largest proportion 
of BSI-POA presented with Staphylococcus aureus (48.4%), followed by Enterococcus 
faecalis/faecium (20.3%), Klebsiella pneumoniae (16.2%), Streptococcus pneumoniae (8.7%), 
Pseudomonas aeruginosa (4.2%), and Acinetobacter baumannii (2.2%). Overall, 44% of those 
admitted from nursing homes presented with antibiotic resistant strains versus 34% from other 
hospitals and 31% from private homes, p = 0.002. Understanding the risk factors of patients who 
present to the hospital with BSI could enable timely interventions and better patient outcomes. 
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Introduction  
Bloodstream infection present on hospital admission (BSI-POA) is a life threatening 
condition that results in high costs and resource utilization (Sogaard M, Norgaard M, Dethlefsen 
C, & Schonheyder HC, 2011). In a previous study conducted at the same site as the current 
study, the incidence of BSI-POA was reported as 18.6 per 1,000 discharges (Cohen et al., 2013), 
while overall population-based incidence of BSI-POA in Canada , Europe and U.S. range from 
81.6 to 189 per 100,000 person years (Laupland, 2013; Sogaard M et al., 2011; Uslan et al., 
2007). In-hospital case fatality rates associated with BSI-POA have been estimated between 15% 
and 55% (Kontula, Skogberg, Ollgren, Jarvinen, & Lyytikainen, 2016; Sogaard M et al., 2011). 
Concerns about the increasing frequency of BSI-POA have been noted, especially due to 
multiply-resistant organisms (Orsini et al., 2012). 
Although a number of population-based studies have investigated BSI (Artero et al., 
2010; Kontula et al., 2016; Uslan et al., 2007), few have distinguished between community- and 
healthcare-associated infections and such data are necessary for targeting treatment and 
prevention efforts. Even less is known about the prevalence of BSI-POA by admission source 
(e.g., other hospital, skilled nursing facility (SNF), private home), an important factor that can 
inform interventions. Further, various studies have reported different risk factors for BSI-POA; 
more recent data suggest that risks are increased among patients with diabetes (McKane et al., 
2014), age and comorbid conditions (Artero et al., 2010). However, many studies on BSI-POA 
have been limited to specific organisms (Courjon et al., 2015; Wang et al., 2015), single 
institutions (Artero et al., 2010), long-term care (High et al., 2009) or intensive care units (Artero 
et al., 2010).  
Few recent population-based studies have evaluated risk factors for BSI-POA, and we are 
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unaware of any studies focusing solely on BSI-POA with antimicrobial resistant organisms by 
admission source. The following variables which could have a potential impact on the study 
outcome were examined as potential confounders: age, sex, renal failure, chronic dermatitis, 
malignancies, diabetes mellitus, admission source and Charlson Comorbidity Index (CCI) 
(Charlson, Pompei, Ales, & MacKenzie, 1987). Understanding the characteristics that put 
patients at risk for BSI-POA and knowing the causative organisms for those BSIs could provide 
vital information to detect and treat emerging pathogens and potentially reduce resistance and 
mortality rates (Kontula et al., 2016). Therefore, the purpose of this study was to measure 
prevalence and describe the risk factors of patients with BSI-POA, and determine the prevalence 
of resistance in isolates by admission source.  
Methods  
Design, Setting and Sample 
We conducted a retrospective cohort study using data from a larger study funded by the 
National Institutes of Health (Health Information Technology to Reduce Healthcare-Associated 
Infections, R01NR010822) previously summarized in Apte (Apte, Neidell, et al., 2011), 
including all adult patients (age ≥18 years) discharged between January 1, 2006 and December 
31, 2014 from three hospitals which are part of a large academic health system in New York 
City. The three facilities include a 220-bed community hospital and two tertiary/quaternary care 
hospitals with 650 and 850 beds, which serve a diverse group of patients. A total of 713,739 
discharges occurred during the data collection period, data were available for 315,010 patients 
from private homes, SNFs and other hospitals (Figure 3.2). The institutional review boards of 
Columbia University Medical Center and Weill Cornell Medical Center approved the study. 
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Data Collection  
Data were extracted from a clinical data warehouse containing various electronic sources 
shared by the hospitals including laboratory reports and administrative records which provided 
age, gender, admission source and International Classification of Diseases, 9th Revision, Clinical 
Modification (ICD-9-CM) diagnosis codes. Health status at the time of admission was 
determined based on ICD-9-CM diagnosis codes with symptoms present on admission and 
included the following diagnoses: diabetes mellitus, burns, chronic dermatitis, malignancies, 
renal failure and weighted CCI scores.  
Measures  
A team of clinicians and researchers used electronically available data to develop and 
validate electronic algorithms to identify BSI based on the Centers for Disease Control and 
Prevention (CDC) National Healthcare Safety Network (NHSN) definitions (Centers for Disease 
Control and Prevention, 2016a). Patients who presented with a BSI within 48 hours of admission 
were considered to have BSI-POA. Patients discharged from the hospital and then readmitted 
within 30 days with a BSI were excluded. The algorithms utilized microbiology results and ICD-
9-CM billing codes to identify infections and antimicrobial susceptibility patterns for the 
following six organisms: Staphylococcus aureus, Pseudomonas aeruginosa, Enteroccous 
faecalis/faecium, Streptococcus pneumoniae, Klebsiella pneumoniae, and Acinetobacter 
baumannii, selected because they were among the most prevalent organisms causing BSI and 
also commonly develop resistance to one or more antimicrobials (World Health Organization, 
2015). Antimicrobial resistance for the six organisms studied was defined as follows: S. aureus – 
oxacillin; P. aeruginosa – levofloxacin; E. faecalis/faecium – vancomycin; S. pneumoniae – 
penicillin G and penicillin V; K. pneumoniae – imipenem/meropenem; and A. baumannii – 
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ampicillin-sulbactam. Development and validation of definitions are summarized in Apte (Apte, 
Neidell, et al., 2011). 
Statistical Analysis    
Descriptive statistics were computed for all variables including percentages, frequencies, 
means, and standard deviations. Bivariate analyses were performed to determine the association 
between BSI-POA and the following potential predictor variables (age, sex, renal failure, chronic 
dermatitis, malignancies, diabetes mellitus, admission source and CCI). Chi-square tests were 
used for categorical variables and Wilcoxon rank-sum test for the CCI. Those variables 
significantly associated with BSI-POA in the bivariate analyses (p < 0.05) were then included in 
a multiple logistic regression model. Burns were not included in the multivariable analysis due to 
small sample size (n=4). Using chi-square or Wilcoxon rank sum, we compared excluded 
patients with the rest of the sample and found no statistically significant (p<0.05) differences 
with regard to age and sex. For patients with more than one admission during the data collection 
period, only the first admission was included.  
Next, for each of the six organisms studied, the proportion of antibiotic-resistant isolates 
was computed. Bivariate analyses were performed to compare the proportion of antibiotic-
resistant strains by admission source separately for each organism using Chi-square or Fisher’s 
exact test. Data analyses were conducted using SAS version 9.3 (SAS Institute Inc., Cary, NC). 
Results   
Of the 713,739 discharges during the data collection period, admission source was 
available from 315,010 (44%). SNFs, private homes and other hospitals accounted for 2%, 36% 
and 6% respectively. Among the 315,010 discharges were 5,307 cases of BSI-POA (1.7%). Male 
patients were more likely to be admitted with a BSI as compared to female patients (53.3% vs. 
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46.7%). Admission source, age, gender, burns, chronic dermatitis, diabetes mellitus, 
malignancies and renal failure were significantly associated with BSI-POA in bivariate analyses. 
Patients with BSI-POA had a significantly higher mean CCI score (mean: 2.9 +/- standard 
deviation: 2.6, compared to those patients without BSI-POA mean: 1.8 +/- standard deviation: 
2.3), p < 0.001 (Table 3.2). 
In the multivariable analysis shown in Table 3.3, significant predictors of BSI-POA 
included renal failure, chronic dermatitis, malignancies, older age, male gender, CCI and 
admission from SNFs. Patients with a diagnosis of diabetes mellitus were significantly less likely 
to be admitted with BSI-POA.     
Among patients admitted with BSI with one of the six organisms studied (n = 1,509), the largest 
proportion presented with S. aureus (n = 731, 48.4%), followed by E. faecalis/faecium (n = 306, 
20.3%), K. pneumoniae (n = 244, 16.2%), S. pneumoniae (n = 131, 8.7%), P. aeruginosa (n = 65, 
4.2%) and A. baumannii (n = 33, 2.2%). A third of the BSI-POA cases with these organisms 
were antibiotic resistant. Table 3.4 summarizes the rates of isolates causing BSI-POA with these 
six organisms, comparing patients by admission source. The overall proportion of resistant 
organisms was significantly greater among patients admitted from a NH as compared with other 
sources (p = 0.002), but when stratified by organism, only S. aureus had a significantly higher 
proportion of resistant strains in patients admitted from NHs. 
Discussion   
To our knowledge, this is the first study to assess the prevalence, potential risk factors 
and predictors associated with BSI-POA and the prevalence of resistance in isolates by 
admission source using a large sample size and data collected over a 9-year time period. Even 
when accounting for age, patients who were admitted from SNFs were significantly more likely 
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to have a BSI-POA than patients who were admitted from private homes or other hospitals. 
Consistent with our findings, other investigators examined BSI among NH and non-NH residents 
and established that NH exposure was a risk factor for BSI-POA caused by gram-positive 
organisms (Huang et al., 2012) and another study reported that residence in a long-term care 
facility was associated with gram-negative BSI-POA (Pop-Vicas et al., 2009). Limitations of 
these studies included the fact that patients were from a single hospital. In the current study, we 
included several hospitals.  
 Similar to our results, others have found age and male gender to be significant predictors 
of BSI-POA (Akoua-Koffi et al., 2015; Uslan et al., 2007). Among the patient characteristics 
studied, patients with renal failure, malignancies and chronic dermatitis had the highest odds of 
being admitted with a BSI. These findings are consistent with at least two previous studies that 
reported renal failure and malignancies to be associated with BSI-POA (Cheong et al., 2008; 
Rodriguez-Bano et al., 2010). Patients with these conditions generally present with multiple 
comorbidities, including changes in immune function which influence their risk of BSI 
acquisition (James et al., 2008; Stewart et al., 2009) and dermatitis which compromises the skin 
barrier (Watson & Kapur, 2011). 
Among the organisms studied, S. aureus accounted for almost half of the isolates 
associated with BSI-POA and a higher proportion of resistant strains among those admitted from 
SNFs compared with those admitted from private homes and other hospitals. Reports of 
resistance in S. aureus, primarily methicillin-resistant S. aureus (MRSA) are common in this 
setting. In Northern Italy, long-term care residents were more likely to be colonized with MRSA 
(p < 0.0001) than geriatric patients in an acute-care hospital (March et al., 2010).  
 Consistent with other studies, there was also a higher proportion of resistant strains of K. 
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pneumoniae and A. baumannii causing BSI-POA among patients admitted from SNFs. Pop-
Vicas and colleagues (2009) reported a 16-fold increase in BSI caused by gram-negative bacteria 
including K. pneumoniae among the elderly, particularly those residing in long-term care (Pop-
Vicas et al., 2009). Similarly, A. baumannii was initially recognized as a hospital-associated 
infection (Maragakis & Perl, 2008), but is being increasingly reported among people in the 
community (Marchaim et al., 2012; Venkatachalam et al., 2014).  
 Most cases of P. aeruginosa BSI-POA were admitted from private homes. Cases of 
community-associated P. aeruginosa have been noted among vulnerable individuals such as 
those with cystic fibrosis, and rarely, cases have been noted among healthy individuals 
(Huhulescu et al., 2011; Kunimasa et al., 2012). Resistant strains, however, were highest among 
patients transferred from another hospital; this is not surprising considering that patients who 
have had previous prolonged contact with healthcare environments are exposed to more 
multidrug resistant pathogens and are more likely to have received antibiotics (Huang et al., 
2010; Karkada, Adamic, Kahn, & Iwashyna, 2011). Twenty percent of the S. pneumoniae 
resistant strains were isolated from patients admitted from private homes, perhaps related to prior 
antibiotic exposure (Lynch & Zhanel, 2009). We found a similar resistance pattern for E. 
faecalis/faecium among all admission sources. Likewise, a team of researchers reported that E. 
faecalis/faecium has emerged as a cause of multidrug resistance and poses a challenge across 
healthcare settings (Arias, Contreras, & Murray, 2010). Our results for five of the six organisms 
we assessed were not significant, possibly due to the small number of organisms with resistant 
strains. Among the six organisms studied, resistant strains in isolates causing BSI-POA were 
high for patients admitted from private homes, other hospitals, and SNFs (31%, 34% and 44% 
respectively), p = 0.002. Therefore, when patients are admitted with a BSI from these settings, 
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prospective surveillance might be indicated.   
Our findings provide new insight into the profiles of patients arriving at the hospital with 
BSI. Multivariable logistic regression identified seven risk factors that predict BSI-POA. 
Emergency department staff can utilize these criteria to identify patients with bloodstream 
infections and begin empiric antibiotic therapy sooner. Having specific data about the prevalence 
of antibiotic resistance among common pathogens in patients arriving from nursing homes and 
the community can improve the specificity and efficacy of initial antibiotic therapy. Such 
approach could notably reduce mortality in patients with bacteremia (Artero et al., 2010; Yang et 
al., 2013).  
Limitations 
Although this study included a large sample, it had limitations. Definitions for infections 
were based on validated electronic algorithms, which did not include data on patient symptoms. 
The retrospective nature of the study precluded the collection of some clinical data such as 
dosage, timeliness and appropriateness of previously prescribed antibiotics or smoking history, 
which might have resulted in confounding. Moreover, observations lacking admission source 
were not included. We examined a limited number of organisms, based on those frequently 
isolated in the study facilities. Furthermore, our sample was from hospitals in one metropolitan 
region, so results might not be generalizable to rural communities. 
Conclusion 
Shifts in healthcare delivery with much higher levels of complex medical care being 
delivered in the community might have contributed to the dissemination of resistant organisms 
and hospital-acquired infections into the community (Johannes, 2008). Therefore, the ability to 
identify risk factors associated with antimicrobial resistance is critical, and this information 
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Table 3.1 Variables, Level of Analysis and Operational Definitions 
 
  Variable Level of analysis Operational definitions 
Agent   
BSI-POA Dichotomous Patients who presented with a BSI ≤48 hours of admission 
Host Variables   
Age Categorical Age in number of years  
(reference = 18-64), 65-84 years, ≥85 years  
Gender Dichotomous Male or female 
*Comorbid Conditions   
     Renal Failure Dichotomous ICD-9 code 584 present on admission 
     Malignancy  Dichotomous ICD-9 codes 140-239 (except 210-229 benign neoplasms) 
present on admission 
     Burn  Dichotomous ICD-9 code 940-949 present on admission 
     Chronic Dermatitis Dichotomous ICD-9 code 692 present on admission 
     Diabetes Mellitus Dichotomous ICD-9 Code 250 present on admission 
     Charlson Comorbidity 
     Index               
Continuous Charlson Comorbidity score on admission 
Environment Variables   
Admission Source   
     SNF stay Dichotomous Yes or no 
     Private Home Dichotomous Yes or no 
     Hospital Transfer Dichotomous Yes or no 
 
*All comorbid conditions are regarded as present on admission and are based on ICD-9 codes  
BSI-POA = Bloodstream infection present on hospital admission 
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Table 3.2 Description of Study Population and Incidence of Bloodstream Infection Present 





n = 5,307 n (%) 
Non-BSI-POA  




Admission source    <0.001 
     Skilled nursing facility 735 (13.8%) 15,036 (4.9%)  
     Private home 4,014 (75.6%)  254,290 (82.1%)  
     Hospital transfer 558 (10.5%) 40,377 (13%)  
Age category   <0.001 
     18-64 years 2,433 (45.8%) 181,488 (58.6%)  
     65-84 years 2,035 (38.3%) 99,371 (32.1%)  
     ≥85 years 839 (15.8%) 28,844 (9.3%)  
Gender   <0.001 
     Female 2,478 (46.7%) 171,843 (55.5%)  
     Male 2,829 (53.3%) 137,860 (44.5%)  
Comorbid Conditions    
     Burns 4 (0.1%) 2,342 (0.8%) <0.001 
     Chronic dermatitis 674 (12.7%) 15,271 (4.9%) <0.001 
     Diabetes mellitus 1,512 (28.5%) 67, 208 (21.7%) <0.001 
     Malignancies 1,128 (21.3%) 41,072 (13.3%) <0.001 
     Renal failure 2,140 (40.3%) 50,008 (16.1%) <0.001 
Charlson Comorbidity 
Index score: mean  
[standard deviation] 
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Table 3.3 Associations Between Patient Characteristics and Bloodstream Infection Present 




Odds Ratio (95% 
Confidence Interval) 
Renal failure 2.63 (2.47-2.81) 
Chronic dermatitis 2.21 (2.03-2.41) 
Malignancies 1.49 (1.36-1.61) 
Age (reference = 18-64 years)   
     ≥85 years 1.44 (1.32-1.56) 
     65-84 years 1.14 (1.08-1.21) 
Male (reference = female) 1.24 (1.17-1.31) 
Charlson Comorbid Index 1.06 (1.04-1.07) 
Diabetes mellitus  0.93 (0.87-1.00) 
Admission source (reference = *SNF)  
     Private home 0.44 (0.41-0.48) 
     Hospital transfer 0.38 (0.34-0.42) 
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Table 3.4 Isolates Causing Bloodstream Infection Present on Admission (BSI-POA) by 
Admission Source 
 
Isolate Total Hospital 
Transfer  
Private    
Home 




   Resistant    
n (%)              
Resistant     
n (%) 
Resistant    
n (%) 
 
S. aureus    731 43 (41%) 200 (38%) 60 (58%) 0.002* 
P. aeruginosa 64 4 (44%) 14 (27%) 1 (25%) 0.07** 
S. pneumoniae 131 0 (0%) 25 (20%) 1 (17%) 0.26** 
K. pneumoniae 244 7 (28%) 52 (27%) 10 (36%) 0.65* 
E. faecalis/faecium 306 13 (25%) 47 (23%) 12 (26%) 0.85* 
A. baumannii 33 1 (14%) 3 (14%) 1 (20%) 0.26** 
Total 1509 68 (34%) 341 (31%) 85 (44%) 0.002* 
*Chi-square  
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Chapter Four: Risk for Subsequent Hospital-Associated Infection Among Patients with a 
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*Comorbid conditions = Renal failure, malignancies, HIV and diabetes mellitus 
BSI-POA = Bloodstream infection present on hospital admission 
ICU = Intensive care unit 
 
Adapted from Clark, E. G. (1954). Natural history of syphilis and levels of prevention. Br J 
Vener Dis, 30(4), 191-197. 
 
Chapter Four, to examine the risk for hospital-associated infection (HAI) among patients 
with bloodstream infection present on hospital admission (BSI-POA), assessed the interaction 
between the host and the environment in the development of agent (subsequent HAI) using the 
epidemiologic triad, as adapted in Figure 4.1. Age, gender, renal failure, malignancies, HIV, 
diabetes mellitus and Charlson Comorbidity Index (CCI) were placed in the host category. ICU 
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Abstract 
The risk and outcomes of acquiring a hospital-associated infections (HAI) among patients 
admitted with a bloodstream infection (BSI-POA) have not been well described. The objective of 
this study was to examine the incidence and risk factors for developing a subsequent HAI, 
specifically catheter-associated urinary tract infection (CAUTI), pneumonia (PNU) and surgical 
site infection (SSI), and compare length of stay and mortality between patients with a BSI-POA 
who develop an HAI and those who do not. We conducted a retrospective cohort study of 
patients aged ≥18 years discharged from three hospitals in New York City between 2006 and 
2014. Patients who presented with a BSI within 48 hours of admission were considered to have 
BSI-POA and HAI was defined using standardized surveillance definitions among infections 
occurring ≥ 48 hours after admission. There were 761 (6.7%) HAIs among the 11,436 patients 
with BSI-POA. Incidence rates were: CAUTI 5.03 infections per 1,000 catheter days, PNU 2.7% 
among BSI-POA patients and SSI 9.2% of surgical patients. In multivariate regression analyses, 
significant risk factors for CAUTI were intensive care unit (ICU) stay and higher Charlson 
Comorbidity Index (CCI) scores. Male gender, malignancy, HIV, ICU stay, and skilled nursing 
facility stay were significantly associated with PNU. Diabetes mellitus, ICU stay and higher CCI 
scores were significant predictors for SSI. Patients who developed an HAI had a higher mean 
length of stay (mean: 35.0 +/- SD: 29.8), compared with those who did not develop an HAI 
(mean: 12.4 +/- SD: 11.9), p <0.001. The mortality rate for patients who developed an HAI was 
23.9% compared with 11.6% for those who did not develop an HAI, p <0.001. Patients admitted 
with a BSI were at risk for a subsequent HAI, but risk factors differed by type of infection. 
Overall, HAIs were significantly correlated with a longer length of hospital stay and PNU was 
associated with a higher risk for mortality (OR: 1.87, 95% CI: 1.43-2.44). 
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Introduction  
Hospital-associated infections (HAIs) are among the most common complications of 
hospital care, with over 700,000 events occurring annually and affecting one in 25 hospitalized 
patients (Centers for Disease Control and Prevention, 2014). Nearly 99,000 deaths occur each 
year from HAI making it the 10th leading cause of death, with a projected annual cost of $9.8 
billion (Centers for Disease Control and Prevention, 2014; Zimlichman et al., 2013). The burden 
of disease attributable to HAIs is a major patient safety issue and has resulted in regulatory 
action such as financial penalty from Centers for Medicare and Medicaid Services (Centers for 
Medicare & Medicaid Services, 2015). 
All patients are at risk for developing HAI, but the risk may even be greater in 
individuals already medically compromised such as patients with bloodstream infections present 
on hospital admission (BSI-POA). Factors such as organ dysfunction, multiple co-morbidities 
and increased use of invasive devices are common among patients with BSI-POA (Artero et al., 
2010; Laupland & Church, 2014; Lenz et al., 2012), which could lead to increased risk for HAI. 
The resulting HAI may cause greater severity of illness, longer hospitalization, higher risk of 
mortality, and escalating cost (Stone, 2009). Conditions associated with immune-compromise 
such as diabetes mellitus (Tsakiridou et al., 2013), malignancies (Kamboj & Sepkowitz, 2009), 
HIV and renal failure (Kurts, Panzer, Anders, & Rees, 2013; Panis, Matsuo, & Reiche, 2009) 
predispose patients to opportunistic infections. However, associations between these exposures 
and HAI among individuals admitted to the hospital with a BSI have not been analyzed. We 
controlled for these variables as well as other possible confounders. Since many HAIs are 
preventable, identifying contributing factors could potentially reduce healthcare expenditure, 
length of stay and mortality (Magill et al., 2014). Hence, the aims of this study were to examine 
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the incidence and risk factors for developing a subsequent HAI among patients admitted with a 
BSI, and compare length of stay and mortality between patients admitted with a BSI who 
develop HAI and those who do not.   
Methods 
Design, Setting and Sample   
This retrospective cohort study was performed using data obtained from a large electronic 
database that merged clinical and administrative data for the years 2006 to 2014 from all 
inpatient admissions from a large academic health system located in New York City. The data 
collected included over 700,000 discharges of patients ≥18years of age from a 300-bed 
community hospital and two tertiary/quaternary care hospitals with 650 and 850 beds. The 
sample for this study is a subset of the entire study population which included 11,436 patients 
≥18years of age with a BSI-POA. Institutional review board approval was obtained with a 
waiver of individual consent. 
Data Collection  
Data extracted included 1) demographics; 2) laboratory reports; 3) device utilization data 
such as urinary catheter and mechanical ventilation; 4) patient medical history; 5) inpatient 
record including previous hospitalization, length of stay and intensive care unit (ICU) stay; 6) 
skilled nursing facility (SNF) stay; 7) Charlson Comorbidity Index (CCI) (Charlson et al., 1987) 
and 8) International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) 
codes for the following conditions: renal failure, malignancies, HIV and diabetes mellitus. The 
HAIs examined included catheter-associated urinary tract infection (CAUTI), pneumonia (PNU) 
and surgical site infection (SSI).  
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Study Definitions  
Patients who presented with a BSI ≤ 48 hours of admission and had no history of 
hospitalization within the previous 30 days were considered to have BSI-POA. Definitions of 
HAI were based on surveillance definitions from Centers for Disease Control and Prevention 
(CDC) National Healthcare Safety Network (NHSN) (www.cdc.gov/nhsn/about.html) and 
occurred >	48 hours after hospital admission. In cases where specific data were not available 
electronically (e.g., urinary symptoms), a team of clinicians and researchers developed 
algorithms to identify infections as described in Apte, et al., 2011 (Apte, Neidell, et al., 2011). In 
previous work, central line duration and dates of diagnosis were 100% consistent between the 
electronic algorithms and expert chart review (Ippolito, Larson, Furuya, Liu, & Seres, 2015). 
Catheter-associated UTIs were defined as occurring between one day after urinary catheter 
insertion and 72 hours after removal with positive urine culture with any organism, that is, ≥ 105 
colony forming units per ml of urine and no more than one other species of microorganism, or 
positive urine culture with any organism, that is, 103–105 colony forming units per ml of urine 
and no more than one other species of microorganism and pyuria (≥ 3 white blood cells per high 
power field in urine microscopy) within ± 48 hours of positive culture. The diagnosis of PNU 
was based on ICD-9-CM coding for PNU, including all PNU codes and positive respiratory 
cultures with any organism (Apte, Neidell, et al., 2011). A SSI was defined as any NHSN 
operative procedure (as ICD-9-CM-procedure code) performed and positive wound culture for 
any organism within 30 days following the procedure (Apte, Landers, Furuya, Hyman, & Larson, 
2011). 
Statistical Analysis 
The incidence of each HAI was calculated by dividing the number of infections by the 
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total population at risk during the study period: for CAUTI: number of UTI/1,000 catheter days, 
for PNU: number of pneumonias/total patients with BSI-POA, for SSI: number of SSI/number of 
patients undergoing a surgical procedure. Descriptive statistics were computed including 
percentages and frequency tables for categorical variables and mean, median and standard 
deviation for continuous variables. The relationships between each type of infection and 
potential predictor or confounding variables were calculated. For categorical variables, Chi 
square tests were used and continuous variables were calculated using Student t-test for age and 
Wilcoxon rank-test for CCI. Odds ratios (OR) and 95% confidence intervals (CI) were computed 
for all associations, statistical significance was determined by a p value of < 0.05. Multivariable 
logistic regression models were then created for each outcome variable (CAUTI, PNU and SSI). 
The variables examined as potential confounders were gender, age, renal failure, malignancy, 
HIV, diabetes mellitus, ICU stay, previous stay in a skilled nursing facility (SNF) and CCI 
(Charlson et al., 1987; Cornejo-Juarez et al., 2016; Dasgupta et al., 2015). HIV was not included 
in the multivariable analysis for SSI due to small sample size. For patients with more than one 
admission during the data collection period, only the first admission was included.  
Multivariable logistic regression models were used to examine length of stay among 
patients who developed HAI versus those who did not for two categories, based on the median 
length of stay: 3-10 days (reference category) and 11-60 days. We truncated length of stay from 
3 to 60 days because <3-day stay does not meet HAI criteria and >60-day stay resulted in a few 
outliers that would markedly distort the length of stay analysis (Niskanen, Reinikainen, & Pettila, 
2009; Southern, Berger, Bellin, Hailpern, & Arnsten, 2007; Verburg, de Keizer, de Jonge, & 
Peek, 2014). Comorbid conditions previously identified in the literature and independently 
examined as potential covariates included gender, age, ICU stay and CCI (Chant, Smith, 
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Marshall, & Friedrich, 2011; Feng, Amoateng-Adjepong, Kaufman, Gheorghe, & Manthous, 
2009; Li et al., 2016; Strand et al., 2010). For SSI, we categorized surgical procedures which 
occurred in the operating room as ≥ 30 minutes in duration (long procedures) or < 30 minutes 
(short procedures). Because most patients who died had a short length of stay, we removed them 
from the length of stay analysis. 
Finally, multivariable logistic regression models were used to determine if patients who 
developed HAI were at increased risk of death compared to patients who did not develop HAI, 
using the same covariates as those examined for length of stay. Data analyses were conducted 
using SAS version 9.3 (SAS Institute Inc., Cary, NC).  
Results 
Characteristics of the Study Population 
There were 11,436 BSI-POA discharges. The mean age for the population was 64.41 
years (standard deviation +/-18.27). Male patients accounted for 53.9%. Clinical comorbid 
conditions included renal failure (38.2%), diabetes mellitus (30%), ICU stay (28.1%), 
malignancy (21.3%), SNF stay (7.3%) and HIV (5.6%).  
Among patients with a BSI-POA there were 761 (6.7%) cases of HAIs. CAUTI incidence 
rate was 5.03 infections per 1,000 catheter days. There were 306 (2.7%) PNU cases, 69% which 
occurred among patients on mechanical ventilation. A total of 170 (9.2%) SSIs occurred among 
patients who had a surgical procedure (n=1,852).  
Risk Factors for HAI 
Table 4.2 compares the incidence and risk factors for infection by infection type. ICU 
stay and CCI were significant risk factors for CAUTI. Odds ratios (95% CI) were 2.25 (1.75-
2.89); 1.04 (1.01-1.09), respectively. Male gender, malignancy, HIV, ICU stay, and SNF stay 
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were significant risk factors for PNU 1.35 (1.06-1.71); 1.48 (1.08-2.04); 2.17 (1.18-4.02); 10.50 
(7.90-13.95); 1.46 (1.02-2.16), respectively. Significant risk factors for SSI included diabetes 
mellitus, 1.79 (1.19-2.69); ICU stay, 1.95 (1.29-2.93) and CCI, 1.03 (1.01-1.12).  
HAI and Length of Stay  
 The median length of hospital stay for all patients with BSI-POA was 9 days (9 days for 
those without an HAI as compared to 29, 31 and 25 days for those who developed a CAUTI, 
PNU or SSI respectively, p <0.001 (Figure 4.2). In the multivariable analysis, after controlling 
for gender, ICU stay, age, CCI and duration of surgery (only in the SSI model), length of stay 
was significantly higher in patients with HAIs compared to patients without HAIs. Age was not a 
significant predictor for length of stay for any of the three types of infections, but the odds of a 
longer stay were significantly greater for each type of infection among those with ICU stays and 
higher CCI scores (Table 4.3). 
HAI and Mortality 
The mortality rate for patients who developed an HAI was 23.9% compared with 11.6% 
for those who did not develop an HAI, p <0.001. Three models were specified, one for each type 
of infection, to describe the associations between HAIs and mortality after adjusting for gender, 
ICU stay, age, CCI (and surgery duration in the SSI model). There was no significant 
relationship between having CAUTI or SSI and mortality, but those who had PNU were more 
likely to die (OR:1.87, 95% CI:1.43-2.44). Across all types of HAI, ICU stay, age and CCI were 
associated with significantly higher risk of mortality and male patients had significantly lower 
odds of death compared with female patients (Table 4.4). 
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Discussion  
 To our knowledge, this is the first study to examine the incidence and risk factors for 
acquiring an HAI, as well as assessing length of stay and mortality among patients admitted to 
the hospital with a BSI.  
Types of Infection  
 
The overall rate of HAI in this population was 6.7%. PNU was the most common 
infection, followed by CAUTI and then SSI. Results from a multistate prevalence survey of 
HAIs among all hospitalized patients estimated that 157,000 PNU occurred in U.S. hospitals in 
2011, 39% of which were ventilator-associated PNU (Magill et al., 2014) compared with 69% 
observed in our study. Another study examined ICU patients in Greece and reported that 
ventilator-associated PNU accounted for 56.1% of all HAIs (Apostolopoulou et al., 2013). 
Differences among infection rates and proportions of ventilator-associated PNU may be 
attributable to differences in geographic locations, hospitals, patient groups or surveillance 
practices, or it is possible that patients admitted with a BSI are at greater risk for this more 
serious infection.  
 The rate of CAUTI in this study (5.03 per 1,000 catheter days), was slightly higher than 
that reported in national data from NHSN acute care hospitals (1.2 – 4.8 infections per 1,000 
catheter days) (Dudeck et al., 2013) and in another study of ICU patients (4.2 per 1,000 catheter 
days) (Apostolopoulou et al., 2013), perhaps also reflecting the high risk nature of patients with 
BSI-POA. 
A systematic review examined 57 studies published between 2002 and 2012 and reported 
a median SSI incidence of 3.7% (Korol et al., 2013). Another study assessed the relative burden 
of HAI in community hospitals and reported an SSI prevalence rate between 0.6 and 4.3% 
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(Lewis, Moehring, Chen, Sexton, & Anderson, 2013), while data from NHSN reported the 
overall SSI rates of 1.9% during 2006 to 2008 (Mu, Edwards, Horan, Berrios-Torres, & Fridkin, 
2011). By contrast, 9.2% of our patient population undergoing surgery developed an SSI, 
possibly related to differences in populations or data collection methods or reflecting the 
increased risk among patients with BSI on admission. Hence, for the three types of HAI 
examined, rates in our study population were slightly higher than those reported in the literature. 
Risk Factors for HAI 
Not surprising, ICU stay was predictive of CAUTI, PNU and SSI after adjusting for 
gender, renal failure, malignancy, HIV, diabetes, admission from a skilled nursing facility, age 
and CCI. Severely ill patients cared for in the ICU typically require extended hospitalization, 
increased use of invasive devices, and are more vulnerable to develop HAIs.  
The CCI was originally developed and validated as a risk of mortality score but is often 
also used as a predictor for other outcomes such as length of stay and HAI with less consistent 
results. One study reported no correlation between CCI scores among patients with and without 
device-associated HAIs (Apostolopoulou et al., 2013) while another found higher CCI scores in 
patients who developed HAI (Emerson et al., 2012). In one recent study no association was 
observed between higher CCI scores and SSI (Voskuijl, Hageman, & Ring, 2014), whereas Khan 
and colleagues reported a significant association between higher CCI scores and SSI (Khan, 
Rooh ul, Zarin, Khalil, & Salman, 2010). A team of researchers has reported higher CCI scores 
in patients with ventilator-associated PNU (Karatas, Saylan, Kostakoglu, & Yilmaz, 2016). In 
our study, higher CCI scores were significantly associated with CAUTI and SSI, but not PNU. 
HAI and Length of Stay and Mortality  
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Consistent with previous studies, patients who developed HAI had significantly longer 
hospital stays (Arefian et al., 2016; Glance, Stone, Mukamel, & Dick, 2011; Rahmqvist et al., 
2016). Further, an ICU stay as well as higher CCI scores were predictive of prolonged length of 
stay in other studies (Abdullah & Al-Salamah, 2009; Arshad et al., 2014; Johnson et al., 2015).  
Although one study reported a higher mortality rate among catheterized patients in a 
geriatric hospital with CAUTI compared to uncatheterized patients (19.2% vs 10.5%; p < 0.05), 
there was no statistically significant difference in mortality between catheterized patients with 
and without CAUTI (19.2% vs 11.3%; p = 0.07) (Vincitorio et al., 2014). Generally, CAUTI is 
not considered to be a serious infection and there was no correlation between having a CAUTI 
and risk for mortality in our population even though they were primarily older and at high risk.  
In our BSI-POA cohort, PNU, ICU stay, age and higher CCI scores were significant 
predictors for higher mortality and men were significantly less like to die than women. The fact 
that overall male patients had a lower risk of dying when controlling for comorbidities and other 
risk warrants additional research. Patients in this study who developed PNU were more likely to 
die compared with those who did not develop PNU. Similarly, in a European multi-center 
prospective study of 201 ICU patients who developed hospital-associated pneumonia, the overall 
30-day mortality rate was almost 30% and those with ventilator-associated pneumonia were 
significantly more likely to die (Herkel et al., 2016). Mortality associated with ventilator-
associated PNU is particularly high (Charles et al., 2014); one team of researchers examined data 
from 112 patients with carbapenem-resistant Enterobacteriaceae- ventilator-associated PNU and 
reported a 30-day mortality of 57.1% (Tuon et al., 2017).  
Researchers found that patients who had a major cancer surgery-associated SSI had 
increased odds of mortality (OR: 3.78, 95% CI 3.56 - 4.02) (Sammon et al., 2013). After 
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controlling for duration of surgery, gender, ICU stay, age and CCI, we found no relationship 
between SSI and mortality (OR: 1.14, 95% CI 0.71-1.83).  
In two recent studies examining cancer patients, the overall HAI rates were higher than 
the rates observed in this study among patients with BSI-POA, 31% (Huoi, Vanhems, Nicolle, 
Michallet, & Benet, 2013) and 40.7% (Cornejo-Juarez et al., 2016), which is not surprising 
because factors associated with malignancies such as extensive antibiotic use, prolonged 
exposure to chemotherapy agents, invasive intravenous lines, cancer-related complications and 
treatment-associated adverse effects greatly impact the risks for HAI (Ariza-Heredia & Chemaly, 
2014; Kostakou, Rovina, Kyriakopoulou, Koulouris, & Koutsoukou, 2014). Notably, however, 
Cornejo-Juarez et al., 2016 found no differences in mortality among HAI versus non-HAI 
patients. 
Limitations 
 First, our study was retrospective in nature and only included data available from the 
electronic records, which were not collected for research purposes and therefore did not include 
data on a number of variables which could be associated with risk of HAI or potential 
confounders. While we used NHSN surveillance definitions for HAI, the retrospective nature of 
the study precluded the collection of some clinical data such as patient symptoms. In addition, 
some HAIs, particularly PNU are difficult to diagnose. In fact, new guidelines for diagnosis and 
treatment of PNU were released in 2016 by the Infectious Diseases Society of America and the 
American Thoracic Society (Kalil et al., 2016). Hence, it is possible that some HAIs were missed 
or mis-diagnosed. Lastly, the study was conducted in hospitals in a single large metropolitan 
area, so results might not be generalizable to other care settings or rural communities. Finally, by 
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examining total length of hospital stay, we did not differentiate between length of stay as a cause 
or an effect of an HAI. 
Conclusion  
In summary, this research adds new information about the incidence and risk for HAI in 
patients admitted with a BSI. PNU was most prevalent type of infection, followed by CAUTI 
and then SSI. Significant risks for each infection were as follows: PNU (ICU stay, HIV, SNF 
stay, male gender and malignancy), CAUTI (ICU stay and CCI) and SSI (ICU stay, CCI and 
diabetes mellitus). Overall, patients who developed HAI had a significantly longer length of stay. 
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Table 4.1 Variables, Level of Analysis and Operational Definitions 
 
  Variable Level of analysis Operational definitions 
Agent   
BSI-POA Dichotomous Patients who presented with a BSI ≤48 hours of admission 
Host Variables   
Age Continuous Age in years 
Gender Dichotomous Male or female 
*Comorbid Conditions   
     Renal Failure Dichotomous ICD-9 code 584 present on admission 
     Malignancy  Dichotomous ICD-9 codes 140-239 (except 210-229 benign neoplasms) 
present on admission 
     HIV  Dichotomous ICD-9 code 042 present on admission 
     Diabetes Mellitus Dichotomous ICD-9 Code 250 present on admission 
     Charlson Comorbidity 
     Index               
Continuous Charlson Comorbidity score on admission 
Environment Variables   
ICU stay Dichotomous Yes or no 
SNF stay Dichotomous Yes or no 
Urinary catheterization Dichotomous Yes or no 
Mechanical ventilation Dichotomous Yes or no 
Type of surgery Categorical ≥ 30 minutes = long procedure  
<30 minutes = short procedure 
Outcomes Variables   
HAI: CAUTI, PNU, SSI Dichotomous Yes or no 
Length of stay Continuous  Days 
Mortality Dichotomous Yes or no 
 
*All comorbid conditions are regarded as present on admission and are based on ICD-9 codes  
BSI-POA = Bloodstream infection present on hospital admission 
ICU = Intensive care unit 
SNF = Skilled nursing facility 
HAI = Hospital-associated infection 
CAUTI = Catheter-associated urinary tract infection 
PNU = Pneumonia 
SSI = Surgical site infection 
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Table 4.2 Multivariable Analysis for Variables Associated with Specific Types of Hospital-Associated Infection Among 





CAUTI: N = 285  PNU: N = 306 SSI: N = 170 
 
N (%)  
 










Odds Ratio (95% 
Confidence Interval) 
Male (ref=female) 139 (48.7) 0.83 (0.65-1.05) 205 (67) 1.35 (1.06-1.71) 66 (38.8) 1.40 (0.91-3.83) 
Renal failure 132 (46.3) 0.91 (070-1.18) 
 
152 (49.7 1.07 (0.83-1.37) 77 (45.3) 1.01 (0.67-1.50) 
Malignancy 54 (18.9) 0.76 (0.52-1.10) 83 (27.1) 1.48 (1.08-2.04) 14 (8.2) 0.54 (0.27-1.04) 
HIV  14 (4.9) 1.26 (0.60-2.65) 
 
23 (7.5) 2.17 (1.18-4.02) 3 (1.8) *  
Diabetes mellitus 85 (29.8) 0.96 (0.72-1.27) 
 
79 (25.8) 0.91 (0.68-1.21) 72 (42.4) 1.79 (1.19-2.69) 
ICU stay 180 (63.2) 2.25 (1.75-2.89) 
 
243 (79.4) 10.50 (7.90-13.95) 98 (57.7) 1.95 (1.29-2.93) 
SNF stay 26 (9.1) 0.85 (0.56-1.29) 
 
32 (10.5) 1.46 (1.02-2.16) 11 (6.47) 1.45 (0.67-3.13) 
 
Agea: mean  
[standard deviation]  
66.3 [17.7] 0.99 (0.99-1.00) 
 



















a Continuous variable 
*: n = 3, too small 
CAUTI = Catheter-associated urinary tract infection 
PNU = Pneumonia 
SSI = Surgical site infection 
ICU = Intensive care unit 
SNF = Skilled nursing facility
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Figure 4.2 Overall Median Length of Stay Among Patients Admitted with a Bloodstream 




CAUTI = Catheter-associated urinary tract infection 
PNU = Pneumonia 
SSI = Surgical site infection 
 
Univariate analysis using Wilcoxon Signed Rank test to compare length of stay in the HAI vs. non-HAI group, p 
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Table 4.3 Length of Stay by Type of Infection Among Patients Admitted with a 





Length of stay 
CAUTI  
Odds Ratio (95% 
Confidence Interval) 
PNU 
Odds Ratio (95% 
Confidence Interval) 
SSI 
Odds Ratio (95% 
Confidence Interval) 
Infection 5.88 (4.47-7.72) 7.95 (5.85-10.81) 1.51 (1.03-2.21) 
 



































a Continuous variable 
CAUTI = Catheter-associated urinary tract infection 
PNU = Pneumonia 
SSI = Surgical site infection 
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Table 4.4 Risk of Mortality by Type of Infection Among Patients Admitted with a 







Odds Ratio (95% 
Confidence Interval) 
PNU 
Odds Ratio (95% 
Confidence Interval) 
SSI 
Odds Ratio (95% 
Confidence Interval) 
Infection 0.79 (0.56-1.01) 1.87 (1.43-2.44) 1.14 (0.71-1.83) 
 
Surgery: duration ≥30min (ref= <30min)  -  -  0.93 (0.63-1.36) 
 

































a Continuous variable 
CAUTI = Catheter-associated urinary tract infection 
PNU = Pneumonia 
SSI = Surgical site infection 
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Chapter Five: Conclusion 
 The purpose of this chapter is to synthesize the findings of this dissertation. The chapter 
begins with a synopsis of the systematic review and meta-analysis describing the current state of 
the science surrounding multidrug resistant-gram negative bacteria (MDR-GNB) in nursing 
home (NH) residents. Following this, a summation of risk factors for bloodstream infection 
present on hospital admission (BSI-POA) is reported. Next, findings evaluating the risks of 
hospital-associated infection (HAI) among patients admitted with a BSI are discussed. The 
chapter concludes with a discussion about the strengths and limitations of this dissertation, after 
which, future research recommendations and implications for policy and practice are presented. 
Summary of Systematic Review and Meta-Analysis 
Our systematic review and meta-analysis identified a high prevalence of MDR-GNB 
among NH residents (27%). Risks for MDR-GNB colonization included advanced age, gender, 
comorbid chronic diseases, history of recurrent hospitalization, increased interaction with 
healthcare workers, frequent antimicrobial exposure, delayed initiation of effective antibiotic 
therapy, presence of medical devices, decreased functional status, advanced dementia, non-
ambulatory status, fecal incontinence, severe sepsis on present on admission and residency in a 
long-term care facility. Of 327 titles and abstracts screened, 12 studies met criteria for review; of 
these, 8 examined MDR-GNB colonization and were therefore eligible for meta-analysis. 
Although the overall quality of the studies was good, weaknesses included variability in MDR-
GNB definitions and half of the studies were co-authored by the same research team. The major 
recommendation from this systematic review is to enhance methodological transparency by 
using a set of standardized definitions when evaluating infections. To the best of our knowledge, 
this is the first systematic review and meta-analysis on this topic. 
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Summary of the Study on Risk Factors for Bloodstream Infection Present on Hospital 
Admission 
 The retrospective analysis of risk factors for BSI-POA confirmed that renal failure, 
chronic dermatitis, malignancies, older age, male gender, Charlson Comorbidity Index (CCI) and 
admission from skilled nursing facilities (SNFs) were risks factors for BSI-POA. The largest 
proportion of BSI-POA was associated with Staphylococcus aureus and the proportion of 
antibiotic-resistant strains was higher among patients who were admitted from SNFs compared 
to patients who were admitted from private homes or transferred from other hospitals. Our 
results imply that upon hospital admission it is crucial to identify patients at risk for BSI with 
antimicrobial resistance, which could influence the management of complicated infections. 
Several studies have examined risks for BSI, but we did not find any study that focused 
exclusively on BSI-POA with antimicrobial resistant organisms by admission source (private 
home, skilled nursing facility or other hospital). 
Summary of Findings on Risk Factors for Hospital-Associated Infection Among Patients 
Admitted with a Bloodstream Infection 
Our retrospective analysis revealed that in patients admitted with a BSI, the following 
variables increased the risk for development of a subsequent HAI: 1) intensive care unit (ICU) 
stay; 2) CCI; 3) SNF stay; 4) HIV; 5) male gender; 6) malignancy and 7) diabetes mellitus. Our 
findings highlight that a subsequent HAI in the BSI-POA cohort is (6.7%). Rates for CAUTI, 
PNU and SSI among patients admitted with a BSI were slightly higher than those reported in 
national averages. Estimates of HAI incidence were difficult to compare between patients 
admitted with a BSI and other groups of patients because of differences in patient characteristics 
and other factors such as differences in detection rates or diagnostic criteria. Several studies have 
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found that various factors influence the risk of HAI including immune dysfunction, antibiotic 
use, severity of illness and frequent interactions with the healthcare system (Ariza-Heredia & 
Chemaly, 2014; Kostakou et al., 2014; Sydnor & Perl, 2011).  
CAUTI, PNU, SSI, ICU stay and higher CCI scores were associated with prolonged 
length of stay, substantiating evidence from previous studies. Patients with PNU, ICU stay, older 
age and higher CCI scores were significantly more likely to die. Patient care procedures for early 
diagnosis of patients at risk and adherence to infection prevention strategies might be beneficial 
to reduce infections. This was the first study to assess the risk for developing subsequent HAI 
after admission with a BSI. 
Strengths and Limitations  
 There were several strengths to this dissertation. First, the systematic review followed 
Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines and well-
designed protocols to strengthen the robustness of the study. The expertise of Columbia 
University Health Science Center librarian was used for the search and a validated tool was used 
to assess the quality of each study. Studies were carefully reviewed and data extracted by two 
reviewers. Discrepancies were resolved with expertise from research scientists proficient in 
systematic review methodologies and infection control measures. The systematic review and 
meta-analysis provides new evidence on the prevalence of MDR-GNB colonization and infection 
rates, bacterial isolates and common sites for colonization. 
 For the quantitative analyses for the retrospective studies, strengths included the use of 
large dataset that included information collected over a period of 9-years on a heterogeneous 
patient population. Because a large representative sample from two tertiary hospital centers and a 
community hospital was examined, our findings related to risk factors for BSI-POA, developing 
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subsequent HAI and its effects on length of stay and mortality have strong external validity. 
Furthermore, data were analyzed at the patient level to enable greater granularity. 
This dissertation also has some limitations. The systematic review was limited to studies 
published in English language and in peer-reviewed journals, exclusion of grey literature and 
non-English studies may have led to studies being missed. Because retrospective cohort design 
was used for the quantitative studies, we were unable to infer causation between the predictor 
variables and the outcomes. The studies were secondary analyses, so we were unable to control 
the exposure or outcome variables or confirm the accuracy of the data collected. For example, 
ICD-9-codes might have been documented incorrectly, clinical cultures misclassified or 
unavailability of data (e.g., time to antibiotic administration), which might have resulted in 
confounding. 
Implications 
 Despite limitations, the findings of this dissertation have implications for future research, 
policy and practice. 
Future Direction for Research  
 First, focusing on MDR-GNB among NH residents presents an opportunity to improve 
the quality of care in NHs and reduce infections. Identifying a standardized definition for MDR-
GNB and conducting infection prevention intervention studies is recommended. This could help 
with accurate diagnosis, provide better infection prevention measures and enhance 
methodological rigor among studies. 
Second, little is known about the incidence of BSI-POA at the national level since the 
National Healthcare Safety Network, Centers for Disease Control and Prevention’s system for 
tracking healthcare associated infections, does not report surveillance data on POA infections 
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(Centers for Disease Control and Prevention, 2016a). In our analysis, the prevalence of BSI-POA 
was influenced by a patient’s comorbid conditions and admission source (e.g., private home, 
hospital transfer or skilled nursing facility). Also, antibiotic resistant strains varied by admission 
source. Developing and investigating a risk adjustment model would be worthwhile. 
Additionally, future research should consider examining other variables we were not able to 
include such as patient symptoms and history of antimicrobial use to more accurately capture the 
relationship between BSI-POA (including those with antibiotic resistant strains) and patient 
characteristics.  
Lastly, it might be beneficial to prospectively follow patients admitted with a BSI. For 
instance, studies that analyze data including appropriate antimicrobial administration, the timing 
of therapeutic interventions and indication for urinary catheterization could provide meaningful 
information and inform clinical decisions. Moreover, gaining a greater understanding of 
subsequent outcomes (i.e., HAIs, length of stay and mortality) as a result of being admitted with 
a BSI will impact future policy work. 
Implications for Policy   
Our findings support the need to reexamine infection control policies in NHs and 
implement strategies to reduce MDR-GNB colonization rates. Furthermore, a third of BSI-POA 
cases with common nosocomial organisms (Staphylococcus aureus, Pseudomonas aeruginosa, 
Enteroccous faecalis/faecium, Streptococcus pneumoniae, Klebsiella pneumoniae, and 
Acinetobacter baumannii) were antibiotic resistant. Policy recommendations to effectively 
address these rates require development of new drugs together with measures to slow the 
emergence of antibiotic resistant pathogens (Spellberg et al., 2011). Similarly, it might be 
beneficial for hospitals to develop and implement screening guidelines to identify BSI-POA 
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cases and publicly report them. This could increase awareness to act quickly when dealing with 
patients with BSI. Finally, because risks for HAI among those with BSI-POA differ by infection 
type, introducing policy that utilizes a risk assessment process to select suitable therapeutic 
interventions could possibly reduce infections in this patient population.  
Implications for Practice 
 Implications for practice were evident throughout our studies. NH residents are a high-
risk population for colonization with antibiotic-resistant bacteria (Cerceo et al., 2016) and 
patients with BSI-POA have potential risk for rapid deterioration if treatment is delayed 
(Laupland & Church, 2014). The ability to identify risk factors associated with antimicrobial 
resistance is critical, and this information could be used to improve treatment decisions and 
decrease the rate of inappropriate antibiotic administration. Recommendations from our findings 
for private homes and SNFs include decreasing antibiotic over-prescribing, educating patients on 
antibiotic adherence, reinforcing isolation precautions and hand hygiene (Huang, Stewardson, & 
Grayson, 2014; Webster, 2017). Current federal guidelines call for a reduction in antimicrobial 
resistance (White House, 2015), but as it stands, antibiotic resistant bacteria remain a noteworthy 
concern that contribute to adverse patient outcomes (Fleming-Dutra et al., 2016). Implementing 
these recommendations is important to creating a culture of safety in healthcare. 
 Additionally, screening guidelines for BSI-POA might be useful, particularly if they 
include hospital-specific measures that will support decisions for early recognition. The risk 
factors identified in our quantitative studies could be used to develop screening tools; however, 
additional research would be necessary to assess the specificty and sensitivity of those tools. 
Promoting best practices that will prevent subsequent HAI, for example, daily assessment of the 
need for urinary catherter, respiratory care, patient positioning and staff education on signs of 
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infection could reduce adverse clinical effects (Conway, Liu, Harris, & Larson, 2016; Klompas 
et al., 2014).  
 In summary, this dissertation examined the incidence of MDR-GNB in NH residents as 
well as identified incidence and predictors for BSI-POA and HAIs. We also compared length of 
stay and mortality among patients who developed HAI versus those who did not develop HAI. 
Policy makers, healthcare administrators, clinicians and researchers may use this information to 














  75 
References           
Abdullah, M., & Al-Salamah, S. M. (2009). Impact of comorbidity on outcome among acute 
non-traumatic surgical patients. Evaluation of Charlson comorbidity index. Saudi Med J, 
30(2), 228-233.  
Agodi, A., Auxilia, F., Barchitta, M., Brusaferro, S., D'Alessandro, D., Grillo, O. C., . . . Mura, I. 
(2013). Trends, risk factors and outcomes of healthcare-associated infections within the 
Italian network SPIN-UTI. Journal of Hospital Infection, 84(1), 52-58. 
doi:10.1016/j.jhin.2013.02.012 
Akoua-Koffi, C., Tia, H., Plo, J. K., Monemo, P., Cisse, A., Yao, C., . . . Becker, S. L. (2015). 
Epidemiology of community-onset bloodstream infections in Bouake, central Cote 
d'Ivoire. New Microbes New Infect, 7, 100-104. doi:10.1016/j.nmni.2015.06.009 
Apostolopoulou, E., Raftopoulos, V., Filntisis, G., Kithreotis, P., Stefanidis, E., Galanis, P., & 
Veldekis, D. (2013). Surveillance of device-associated infection rates and mortality in 3 
Greek intensive care units. Am J Crit Care, 22(3), e12-20. doi:10.4037/ajcc2013324 
Apte, M., Landers, T., Furuya, E. Y., Hyman, S., & Larson, E. (2011). Comparison of two 
computer algorithms to identify surgical site infections. Surg Infect (Larchmt). 12(6), 
459-464. doi:10.1089/sur.2010.109 
Apte, M., Neidell, M., Furuya, E. Y., Caplan, D., Glied, S., & Larson, E. (2011). Using 
electronically available inpatient hospital data for research. Clin Transl Sci, 4(5), 338-
345. doi:10.1111/j.1752-8062.2011.00353.x 
Arefian, H., Hagel, S., Heublein, S., Rissner, F., Scherag, A., Brunkhorst, F. M., . . . Hartmann, 
M. (2016). Extra length of stay and costs because of health care-associated infections at a 
  76 
German university hospital. Am J Infect Control, 44(2), 160-166. 
doi:10.1016/j.ajic.2015.09.005 
Arias, C. A., Contreras, G. A., & Murray, B. E. (2010). Management of multidrug-resistant 
enterococcal infections. Clin Microbiol Infect, 16(6), 555-562. doi:10.1111/j.1469-
0691.2010.03214.x 
Arias, C. A., & Murray, B. E. (2009). Antibiotic-resistant bugs in the 21st century--a clinical 
super-challenge. N Engl J Med, 360(5), 439-443. doi:10.1056/NEJMp0804651 
Ariza-Heredia, E. J., & Chemaly, R. F. (2014). Infection control practices in patients with 
hematological malignancies and multidrug-resistant organisms: special considerations 
and challenges. Clin Lymphoma Myeloma Leuk, 14 Suppl, S104-110. 
doi:10.1016/j.clml.2014.06.021 
Arshad, H., Ozer, H. G., Thatcher, A., Old, M., Ozer, E., Agarwal, A., . . . Teknos, T. N. (2014). 
Intensive care unit versus non-intensive care unit postoperative management of head and 
neck free flaps: comparative effectiveness and cost comparisons. Head Neck, 36(4), 536-
539. doi:10.1002/hed.23325 
Artero, A., Zaragoza, R., Camarena, J. J., Sancho, S., Gonzalez, R., & Nogueira, J. M. (2010). 
Prognostic factors of mortality in patients with community-acquired bloodstream 
infection with severe sepsis and septic shock. J Crit Care, 25(2), 276-281. 
doi:10.1016/j.jcrc.2009.12.004 
Barnett, A. G., Page, K., Campbell, M., Martin, E., Rashleigh-Rolls, R., Halton, K., . . . Graves, 
N. (2013). The increased risks of death and extra lengths of hospital and ICU stay from 
hospital-acquired bloodstream infections: a case-control study. BMJ Open, 3(10), 
e003587. doi:10.1136/bmjopen-2013-003587 
  77 
Boucher, H. W., Talbot, G. H., Benjamin, D. K., Jr., Bradley, J., Guidos, R. J., Jones, R. N., . . . 
Gilbert, D. (2013). 10 x '20 Progress--development of new drugs active against gram-
negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect 
Dis, 56(12), 1685-1694. doi:10.1093/cid/cit152 
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., . . . 
Bartlett, J. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious 
Diseases Society of America. Clin Infect Dis, 48(1), 1-12. doi:10.1086/595011 
Cassone, M., & Mody, L. (2015). Colonization with Multi-Drug Resistant Organisms in Nursing 
Homes: Scope, Importance, and Management. Curr Geriatr Rep, 4(1), 87-95. 
doi:10.1007/s13670-015-0120-2 
Centers for Disease Control and Prevention. (2014). HAI Data and Statistics.   Retrieved from 
http://www.cdc.gov/hai/surveillance/ 
Centers for Disease Control and Prevention. (2015a). Multi-Site gram-negative bacilli 
surveillance initiative.   Retrieved from http://www.cdc.gov/hai/eip/mugsi.html 
Centers for Disease Control and Prevention. (2015b). Understanding the Epidemiologic Triangle 
through Infectious Disease Working the Epidemiologic Triangle.   Retrieved from 
http://www.cdc.gov/bam/teachers/documents/epi_1_triangle.pdf 
Centers for Disease Control and Prevention. (2016a). CDC/NHSN Surveillance Definitions for 
Specific Types of Infections Retrieved from http://www.cdc.gov/ nhsn/settings.html 
Centers for Disease Control and Prevention. (2016b). Healthcare-associated Infections data and 
statistics Retrieved from http://www.cdc.gov/hai/surveillance/   
Centers for Medicare & Medicaid Services. (2015). National Healthcare Safety Network 
(NHSN).   Retrieved from http://www.cdc.gov/nhsn/about-nhsn/index.html 
  78 
Cerceo, E., Deitelzweig, S. B., Sherman, B. M., & Amin, A. N. (2016). Multidrug-Resistant 
Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for 
Clinical Practice, and Emerging Treatment Options. Microb Drug Resist. 
doi:10.1089/mdr.2015.0220 
Chant, C., Smith, O. M., Marshall, J. C., & Friedrich, J. O. (2011). Relationship of catheter-
associated urinary tract infection to mortality and length of stay in critically ill patients: a 
systematic review and meta-analysis of observational studies. Crit Care Med, 39(5), 
1167-1173. doi:10.1097/CCM.0b013e31820a8581 
Charles, M. P., Kali, A., Easow, J. M., Joseph, N. M., Ravishankar, M., Srinivasan, S., . . . 
Umadevi, S. (2014). Ventilator-associated pneumonia. Australas Med J, 7(8), 334-344. 
doi:10.4066/amj.2014.2105 
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of 
classifying prognostic comorbidity in longitudinal studies: development and validation. J 
Chronic Dis, 40(5), 373-383.  
Chen, H. C., Lin, W. L., Lin, C. C., Hsieh, W. H., Hsieh, C. H., Wu, M. H., . . . Lee, C. C. 
(2013). Outcome of inadequate empirical antibiotic therapy in emergency department 
patients with community-onset bloodstream infections. J Antimicrob Chemother, 68(4), 
947-953. doi:10.1093/jac/dks475 
Cheong, H. S., Kang, C. I., Wi, Y. M., Kim, E. S., Lee, J. S., Ko, K. S., . . . Peck, K. R. (2008). 
Clinical significance and predictors of community-onset Pseudomonas aeruginosa 
bacteremia. Am J Med, 121(8), 709-714. doi:10.1016/j.amjmed.2008.03.034 
Choi, J. P., Cho, E. H., Lee, S. J., Lee, S. T., Koo, M. S., & Song, Y. G. (2012). Influx of 
multidrug resistant, Gram-negative bacteria (MDRGNB) in a public hospital among 
  79 
elderly patients from long-term care facilities: a single-center pilot study. Arch Gerontol 
Geriatr, 54(2), e19-22. doi:10.1016/j.archger.2011.05.026 
Clark, E. G. (1954). Natural history of syphilis and levels of prevention. Br J Vener Dis, 30(4), 
191-197.  
Coban, Y. K. (2012). Infection control in severely burned patients. World J Crit Care Med, 1(4), 
94-101. doi:10.5492/wjccm.v1.i4.94 
Cohen, Choi, Y. J., Hyman, S., Furuya, E. Y., Neidell, M., & Larson, E. (2013). Gender 
differences in risk of bloodstream and surgical site infections. J Gen Intern Med, 28(10), 
1318-1325. doi:10.1007/s11606-013-2421-5 
Cohen., C. C., Pogorzelska-Maziarz, M., Herzig, C. T., Carter, E. J., Bjarnadottir, R., Semeraro, 
P., . . . Stone, P. W. (2015). Infection prevention and control in nursing homes: a 
qualitative study of decision-making regarding isolation-based practices. BMJ Qual Saf, 
24(10), 630-636. doi:10.1136/bmjqs-2015-003952 
Conway, L. J., Liu, J., Harris, A. D., & Larson, E. L. (2016). Risk Factors for Bacteremia in 
Patients With Urinary Catheter-Associated Bacteriuria. Am J Crit Care, 26(1), 43-52. 
doi:10.4037/ajcc2017220 
Cornejo-Juarez, P., Vilar-Compte, D., Garcia-Horton, A., Lopez-Velazquez, M., Namendys-
Silva, S., & Volkow-Fernandez, P. (2016). Hospital-acquired infections at an oncological 
intensive care cancer unit: differences between solid and hematological cancer patients. 
BMC Infect Dis, 16, 274. doi:10.1186/s12879-016-1592-1 
Courjon, J., Munro, P., Benito, Y., Visvikis, O., Bouchiat, C., Boyer, L., . . . Lemichez, E. 
(2015). EDIN-B Promotes the Translocation of Staphylococcus aureus to the 
  80 
Bloodstream in the Course of Pneumonia. Toxins (Basel), 7(10), 4131-4142. 
doi:10.3390/toxins7104131 
D'Agata, E. M., Habtemariam, D., & Mitchell, S. (2015). Multidrug-Resistant Gram-Negative 
Bacteria: Inter- and Intradissemination Among Nursing Homes of Residents With 
Advanced Dementia. Infection Control & Hospital Epidemiology, 36(8), 930-935. 
doi:10.1017/ice.2015.97 
Dasgupta, S., Das, S., Chawan, N. S., & Hazra, A. (2015). Nosocomial infections in the intensive 
care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary 
teaching hospital of Eastern India. Indian J Crit Care Med, 19(1), 14-20. 
doi:10.4103/0972-5229.148633 
Downs, S. H., & Black, N. (1998). The feasibility of creating a checklist for the assessment of 
the methodological quality both of randomised and non-randomised studies of health care 
interventions. J Epidemiol Community Health, 52(6), 377-384.  
Dudeck, M. A., Horan, T. C., Peterson, K. D., Allen-Bridson, K., Morrell, G., Pollock, D. A., & 
Edwards, J. R. (2013). National Healthcare Safety Network (NHSN) Report, data 
summary for 2011, device-associated module.  
Emerson, C. B., Eyzaguirre, L. M., Albrecht, J. S., Comer, A. C., Harris, A. D., & Furuno, J. P. 
(2012). Healthcare-associated infection and hospital readmission. Infection Control & 
Hospital Epidemiology, 33(6), 539-544. doi:10.1086/665725 
Feng, Y., Amoateng-Adjepong, Y., Kaufman, D., Gheorghe, C., & Manthous, C. A. (2009). Age, 
duration of mechanical ventilation, and outcomes of patients who are critically ill. Chest, 
136(3), 759-764. doi:10.1378/chest.09-0515 
  81 
Fleming-Dutra, K. E., Hersh, A. L., Shapiro, D. J., Bartoces, M., Enns, E. A., File, T. M., Jr., . . . 
Hicks, L. A. (2016). Prevalence of Inappropriate Antibiotic Prescriptions Among US 
Ambulatory Care Visits, 2010-2011. Jama, 315(17), 1864-1873. 
doi:10.1001/jama.2016.4151 
Giamarellou, H., & Poulakou, G. (2009). Multidrug-resistant Gram-negative infections: what are 
the treatment options? Drugs, 69(14), 1879-1901. doi:10.2165/11315690-000000000-
00000 
Glance, L. G., Stone, P. W., Mukamel, D. B., & Dick, A. W. (2011). Increases in mortality, 
length of stay, and cost associated with hospital-acquired infections in trauma patients. 
Arch Surg, 146(7), 794-801. doi:10.1001/archsurg.2011.41 
Greenland, S., Gago-Dominguez, M., & Castelao, J. E. (2004). The value of risk-factor ("black-
box") epidemiology. Epidemiology, 15(5), 529-535.  
Gruber, I., Heudorf, U., Werner, G., Pfeifer, Y., Imirzalioglu, C., Ackermann, H., . . . 
Wichelhaus, T. A. (2013). Multidrug-resistant bacteria in geriatric clinics, nursing homes, 
and ambulant care--prevalence and risk factors. Int J Med Microbiol, 303(8), 405-409. 
doi:10.1016/j.ijmm.2013.05.002 
Harris, P., Paterson, D., & Rogers, B. (2015). Facing the challenge of multidrug-resistant gram-
negative bacilli in Australia. Med J Aust, 202(5), 243-247.  
Herkel, T., Uvizl, R., Doubravska, L., Adamus, M., Gabrhelik, T., Htoutou Sedlakova, M., . . . 
Paterova, P. (2016). Epidemiology of hospital-acquired pneumonia: Results of a Central 
European multicenter, prospective, observational study compared with data from the 
European region. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 160(3), 
448-455. doi:10.5507/bp.2016.014 
  82 
High, K. P., Bradley, S. F., Gravenstein, S., Mehr, D. R., Quagliarello, V. J., Richards, C., & 
Yoshikawa, T. T. (2009). Clinical practice guideline for the evaluation of fever and 
infection in older adult residents of long-term care facilities: 2008 update by the 
Infectious Diseases Society of America. Journal of the American Geriatrics Society, 
57(3), 375-394. doi:10.1111/j.1532-5415.2009.02175.x 
Hogardt, M., Proba, P., Mischler, D., Cuny, C., Kempf, V. A., & Heudorf, U. (2015). Current 
prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-
Main district, Germany, 2013. Euro Surveill, 20(26).  
Huang, G. K., Stewardson, A. J., & Grayson, M. L. (2014). Back to basics: hand hygiene and 
isolation. Curr Opin Infect Dis, 27(4), 379-389. doi:10.1097/qco.0000000000000080 
Huang, S. S., Avery, T. R., Song, Y., Elkins, K. R., Nguyen, C. C., Nutter, S. K., . . . Lee, B. Y. 
(2010). Quantifying interhospital patient sharing as a mechanism for infectious disease 
spread. Infection Control & Hospital Epidemiology, 31(11), 1160-1169. 
doi:10.1086/656747 
Huang., M.-Y., Chang, W.-H., Hsu, C.-Y., Tsai, W., Chen, Y.-J., Lee, C.-H., . . . Kung, L.-C. 
(2012). Bloodstream Infections in the Elderly: Effects of Nursing Homes on 
Antimicrobial-Resistant Bacteria. International Journal of Gerontology, 6(2), 93-100. 
doi:http://dx.doi.org/10.1016/j.ijge.2012.01.014 
Huhulescu, S., Simon, M., Lubnow, M., Kaase, M., Wewalka, G., Pietzka, A. T., . . . 
Allerberger, F. (2011). Fatal Pseudomonas aeruginosa pneumonia in a previously healthy 
woman was most likely associated with a contaminated hot tub. Infection, 39(3), 265-
269. doi:10.1007/s15010-011-0096-6 
  83 
Huoi, C., Vanhems, P., Nicolle, M. C., Michallet, M., & Benet, T. (2013). Incidence of hospital-
acquired pneumonia, bacteraemia and urinary tract infections in patients with 
haematological malignancies, 2004-2010: a surveillance-based study. PLoS One, 8(3), 
e58121. doi:10.1371/journal.pone.0058121 
Ippolito, P., Larson, E. L., Furuya, E. Y., Liu, J., & Seres, D. S. (2015). Utility of Electronic 
Medical Records to Assess the Relationship Between Parenteral Nutrition and Central 
Line-Associated Bloodstream Infections in Adult Hospitalized Patients. JPEN J Parenter 
Enteral Nutr, 39(8), 929-934. doi:10.1177/0148607114536580 
James, M. T., Laupland, K. B., Tonelli, M., Manns, B. J., Culleton, B. F., & Hemmelgarn, B. R. 
(2008). Risk of bloodstream infection in patients with chronic kidney disease not treated 
with dialysis. Archives of Internal Medicine, 168(21), 2333-2339. 
doi:10.1001/archinte.168.21.2333 
Johannes, R. S. (2008). Epidemiology of early-onset bloodstream infection and implications for 
treatment. Am J Infect Control, 36(10), S171.e113-177. doi:10.1016/j.ajic.2008.10.003 
Johnson, D. J., Greenberg, S. E., Sathiyakumar, V., Thakore, R., Ehrenfeld, J. M., Obremskey, 
W. T., & Sethi, M. K. (2015). Relationship between the Charlson Comorbidity Index and 
cost of treating hip fractures: implications for bundled payment. J Orthop Traumatol, 
16(3), 209-213. doi:10.1007/s10195-015-0337-z 
Kahvecioglu, D., Ramiah, K., McMaughan, D., Garfinkel, S., McSorley, V. E., Nguyen, Q. N., . 
. . Phillips, C. D. (2014). Multidrug-resistant organism infections in US nursing homes: a 
national study of prevalence, onset, and transmission across care settings, October 1, 
2010-December 31, 2011. Infection Control & Hospital Epidemiology, 35 Suppl 3, S48-
55. doi:10.1086/677835 
  84 
Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., . . . 
Brozek, J. L. (2016). Executive Summary: Management of Adults With Hospital-
acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the 
Infectious Diseases Society of America and the American Thoracic Society. Clin Infect 
Dis, 63(5), 575-582. doi:10.1093/cid/ciw504 
Kallen, A. J., & Srinivasan, A. (2010). Current epidemiology of multidrug-resistant gram-
negative bacilli in the United States. Infection Control & Hospital Epidemiology, 31 
Suppl 1, S51-54. doi:10.1086/655996 
Kamboj, M., & Sepkowitz, K. A. (2009). Nosocomial infections in patients with cancer. Lancet 
Oncol, 10(6), 589-597. doi:10.1016/s1470-2045(09)70069-5 
Karatas, M., Saylan, S., Kostakoglu, U., & Yilmaz, G. (2016). An assessment of ventilator-
associated pneumonias and risk factors identified in the Intensive Care Unit. Pak J Med 
Sci, 32(4), 817-822. doi:10.12669/pjms.324.10381 
Karkada, U. H., Adamic, L. A., Kahn, J. M., & Iwashyna, T. J. (2011). Limiting the spread of 
highly resistant hospital-acquired microorganisms via critical care transfers: a simulation 
study. Intensive Care Medicine, 37(10), 1633-1640. doi:10.1007/s00134-011-2341-y 
Khan, M., Rooh ul, M., Zarin, M., Khalil, J., & Salman, M. (2010). Influence of ASA score and 
Charlson Comorbidity Index on the surgical site infection rates. J Coll Physicians Surg 
Pak, 20(8), 506-509. doi:08.2010/jcpsp.506509 
Klompas, M., Branson, R., Eichenwald, E. C., Greene, L. R., Howell, M. D., Lee, G., . . . 
Berenholtz, S. M. (2014). Strategies to prevent ventilator-associated pneumonia in acute 
care hospitals: 2014 update. Infection Control & Hospital Epidemiology, 35 Suppl 2, 
S133-154.  
  85 
Kontula, K. S., Skogberg, K., Ollgren, J., Jarvinen, A., & Lyytikainen, O. (2016). Early deaths in 
bloodstream infections: a population-based case series. Infect Dis (Lond), 48(5), 379-385. 
doi:10.3109/23744235.2015.1131329 
Korol, E., Johnston, K., Waser, N., Sifakis, F., Jafri, H. S., Lo, M., & Kyaw, M. H. (2013). A 
systematic review of risk factors associated with surgical site infections among surgical 
patients. PLoS One, 8(12), e83743. doi:10.1371/journal.pone.0083743 
Kostakou, E., Rovina, N., Kyriakopoulou, M., Koulouris, N. G., & Koutsoukou, A. (2014). 
Critically ill cancer patient in intensive care unit: issues that arise. J Crit Care, 29(5), 
817-822. doi:10.1016/j.jcrc.2014.04.007 
Kunimasa, K., Ishida, T., Kimura, S., Tanaka, M., Kouyama, Y., Yamashita, S., . . . Tateda, K. 
(2012). Successful treatment of fulminant community-acquired Pseudomonas aeruginosa 
necrotizing pneumonia in a previously healthy young man. Intern Med, 51(17), 2473-
2478.  
Kurts, C., Panzer, U., Anders, H. J., & Rees, A. J. (2013). The immune system and kidney 
disease: basic concepts and clinical implications. Nat Rev Immunol, 13(10), 738-753. 
doi:10.1038/nri3523 
LaCross, A., Groff, M., & Smaldone, A. (2015). Obstetric anal sphincter injury and anal 
incontinence following vaginal birth: a systematic review and meta-analysis. J Midwifery 
Womens Health, 60(1), 37-47. doi:10.1111/jmwh.12283 
Laupland, K. B. (2013). Incidence of bloodstream infection: a review of population-based 
studies. Clin Microbiol Infect, 19(6), 492-500. doi:10.1111/1469-0691.12144 
  86 
Laupland, K. B., & Church, D. L. (2014). Population-based epidemiology and microbiology of 
community-onset bloodstream infections. Clin Microbiol Rev, 27(4), 647-664. 
doi:10.1128/cmr.00002-14 
Laupland, K. B., Gregson, D. B., Flemons, W. W., Hawkins, D., Ross, T., & Church, D. L. 
(2007). Burden of community-onset bloodstream infection: a population-based 
assessment. Epidemiol Infect, 135(6), 1037-1042. doi:10.1017/s0950268806007631 
Lenz, R., Leal, J. R., Church, D. L., Gregson, D. B., Ross, T., & Laupland, K. B. (2012). The 
distinct category of healthcare associated bloodstream infections. BMC Infect Dis, 12, 85. 
doi:10.1186/1471-2334-12-85 
Lewis, S. S., Moehring, R. W., Chen, L. F., Sexton, D. J., & Anderson, D. J. (2013). Assessing 
the relative burden of hospital-acquired infections in a network of community hospitals. 
Infection Control & Hospital Epidemiology, 34(11), 1229-1230. doi:10.1086/673443 
Li, G., Cook, D. J., Thabane, L., Friedrich, J. O., Crozier, T. M., Muscedere, J., . . . Levine, M. 
A. (2016). Erratum to: Risk factors for mortality in patients admitted to intensive care 
units with pneumonia. Respir Res, 17(1), 128. doi:10.1186/s12931-016-0444-2 
Lim, C. J., Cheng, A. C., Kennon, J., Spelman, D., Hale, D., Melican, G., . . . Peleg, A. Y. 
(2014). Prevalence of multidrug-resistant organisms and risk factors for carriage in long-
term care facilities: a nested case-control study. J Antimicrob Chemother, 69(7), 1972-
1980. doi:10.1093/jac/dku077 
Little, M. O. (2011). Diagnostic challenge of bloodstream infections in long-term care. J Am 
Med Dir Assoc, 12(3), 166-168. doi:10.1016/j.jamda.2010.04.013 
  87 
Lubart, E., Segal, R., Haimov, E., Dan, M., Baumoehl, Y., & Leibovitz, A. (2011). Bacteremia in 
a multilevel geriatric hospital. J Am Med Dir Assoc, 12(3), 204-207. 
doi:10.1016/j.jamda.2010.02.017 
Lueangarun, S., & Leelarasamee, A. (2012). Impact of inappropriate empiric antimicrobial 
therapy on mortality of septic patients with bacteremia: a retrospective study. Interdiscip 
Perspect Infect Dis, 2012, 765205. doi:10.1155/2012/765205 
Lynch, J. P., 3rd, & Zhanel, G. G. (2009). Streptococcus pneumoniae: does antimicrobial 
resistance matter? Semin Respir Crit Care Med, 30(2), 210-238. doi:10.1055/s-0029-
1202939 
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., . . . 
Antimicrobial Use Prevalence Survey, T. (2014). Multistate point-prevalence survey of 
health care-associated infections. N Engl J Med, 370(13), 1198-1208. 
doi:10.1056/NEJMoa1306801 
Maragakis, L. L., & Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial 
resistance, and treatment options. Clin Infect Dis, 46(8), 1254-1263. doi:10.1086/529198 
March, A., Aschbacher, R., Dhanji, H., Livermore, D. M., Bottcher, A., Sleghel, F., . . . 
Woodford, N. (2010). Colonization of residents and staff of a long-term-care facility and 
adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin Microbiol 
Infect, 16(7), 934-944. doi:10.1111/j.1469-0691.2009.03024.x 
March, A., Aschbacher, R., Pagani, E., Sleghel, F., Soelva, G., Hopkins, K. L., . . . Woodford, N. 
(2014). Changes in colonization of residents and staff of a long-term care facility and an 
adjacent acute-care hospital geriatric unit by multidrug-resistant bacteria over a four-year 
period. Scand J Infect Dis, 46(2), 114-122. doi:10.3109/00365548.2013.859392 
  88 
Marchaim, D., Chopra, T., Bogan, C., Bheemreddy, S., Sengstock, D., Jagarlamudi, R., . . . 
Kaye, K. S. (2012). The burden of multidrug-resistant organisms on tertiary hospitals 
posed by patients with recent stays in long-term acute care facilities. Am J Infect Control, 
40(8), 760-765. doi:10.1016/j.ajic.2011.09.011 
Mattner, F., Bange, F. C., Meyer, E., Seifert, H., Wichelhaus, T. A., & Chaberny, I. F. (2012). 
Preventing the spread of multidrug-resistant gram-negative pathogens: recommendations 
of an expert panel of the German Society For Hygiene and Microbiology. Dtsch Arztebl 
Int, 109(3), 39-45. doi:10.3238/arzte bl.2012.0039 
10.3238/arztebl.2012.0039 
McKane, C. K., Marmarelis, M., Mendu, M. L., Moromizato, T., Gibbons, F. K., & Christopher, 
K. B. (2014). Diabetes mellitus and community-acquired bloodstream infections in the 
critically ill. J Crit Care, 29(1), 70-76. doi:10.1016/j.jcrc.2013.08.019 
McKay, R., & Bamford, C. (2015). Community- versus healthcare-acquired bloodstream 
infections at Groote Schuur Hospital, Cape Town, South Africa. S Afr Med J, 105(5), 
363-369. doi:10.7196/samj.8183 
Mitchell, S. L., Shaffer, M. L., Loeb, M. B., Givens, J. L., Habtemariam, D., Kiely, D. K., & 
D'Agata, E. (2014). Infection management and multidrug-resistant organisms in nursing 
home residents with advanced dementia. JAMA Intern Med, 174(10), 1660-1667. 
doi:10.1001/jamainternmed.2014.3918 
Mody, L., Bradley, S. F., Galecki, A., Olmsted, R. N., Fitzgerald, J. T., Kauffman, C. A., . . . 
Krein, S. L. (2011). Conceptual model for reducing infections and antimicrobial 
resistance in skilled nursing facilities: focusing on residents with indwelling devices. Clin 
Infect Dis, 52(5), 654-661. doi:10.1093/cid/ciq205 
  89 
Mody, L., Bradley, S. F., & Huang, S. S. (2013). Keeping the "home" in nursing home: 
implications for infection prevention. JAMA Intern Med, 173(10), 853-854. 
doi:10.1001/jamainternmed.2013.330 
Montoya, A., & Mody, L. (2011). Common infections in nursing homes: a review of current 
issues and challenges. Aging health, 7(6), 889-899. doi:10.2217/ahe.11.80 
Morgan, D. J., Liang, S. Y., Smith, C. L., Johnson, J. K., Harris, A. D., Furuno, J. P., . . . 
Perencevich, E. N. (2010). Frequent multidrug-resistant Acinetobacter baumannii 
contamination of gloves, gowns, and hands of healthcare workers. Infection Control & 
Hospital Epidemiology, 31(7), 716-721. doi:10.1086/653201 
Mu, Y., Edwards, J. R., Horan, T. C., Berrios-Torres, S. I., & Fridkin, S. K. (2011). Improving 
risk-adjusted measures of surgical site infection for the national healthcare safety 
network. Infection Control & Hospital Epidemiology, 32(10), 970-986. 
doi:10.1086/662016 
Niskanen, M., Reinikainen, M., & Pettila, V. (2009). Case-mix-adjusted length of stay and 
mortality in 23 Finnish ICUs. Intensive Care Medicine, 35(6), 1060-1067. 
doi:10.1007/s00134-008-1377-0 
O'Fallon, E., Gautam, S., & D'Agata, E. M. (2009). Colonization with multidrug-resistant gram-
negative bacteria: prolonged duration and frequent cocolonization. Clin Infect Dis, 
48(10), 1375-1381. doi:10.1086/598194 
O'Fallon, E., Pop-Vicas, A., & D'Agata, E. (2009). The emerging threat of multidrug-resistant 
gram-negative organisms in long-term care facilities. J Gerontol A Biol Sci Med Sci, 
64(1), 138-141. doi:10.1093/gerona/gln020 
  90 
O'Neil Jim. (2014). Antimicrobial Resistance: Tackling a crisis for the health and wealth of 
nations.   Retrieved from https://amr-review.org/background  
Orsini, J., Mainardi, C., Muzylo, E., Karki, N., Cohen, N., & Sakoulas, G. (2012). 
Microbiological profile of organisms causing bloodstream infection in critically ill 
patients. J Clin Med Res, 4(6), 371-377. doi:10.4021/jocmr1099w 
Otter, J. A., & French, G. L. (2011). Community-associated meticillin-resistant Staphylococcus 
aureus strains as a cause of healthcare-associated infection. Journal of Hospital Infection, 
79(3), 189-193. doi:10.1016/j.jhin.2011.04.028 
Panis, C., Matsuo, T., & Reiche, E. M. (2009). Nosocomial infections in human 
immunodeficiency virus type 1 (HIV-1) infected and AIDS patients: major 
microorganisms and immunological profile. Braz J Microbiol, 40(1), 155-162. 
doi:10.1590/s1517-838220090001000027 
Polin, R. A., Denson, S., & Brady, M. T. (2012). Epidemiology and diagnosis of health care-
associated infections in the NICU. Pediatrics, 129(4), e1104-1109. 
doi:10.1542/peds.2012-0147 
Pop-Vicas, A., Mitchell, S. L., Kandel, R., Schreiber, R., & D'Agata, E. M. (2008). Multidrug-
resistant gram-negative bacteria in a long-term care facility: prevalence and risk factors. 
Journal of the American Geriatrics Society, 56(7), 1276-1280. doi:10.1111/j.1532-
5415.2008.01787.x 
Pop-Vicas, A., & Opal, S. M. (2014). The clinical impact of multidrug-resistant gram-negative 
bacilli in the management of septic shock. Virulence, 5(1), 206-212. 
doi:10.4161/viru.26210 
  91 
Pop-Vicas, A., Strom, J., Stanley, K., & D'Agata, E. M. (2008). Multidrug-resistant gram-
negative bacteria among patients who require chronic hemodialysis. Clin J Am Soc 
Nephrol, 3(3), 752-758. doi:10.2215/cjn.04651107 
Pop-Vicas, A., Tacconelli, E., Gravenstein, S., Lu, B., & D'Agata, E. M. (2009). Influx of 
multidrug-resistant, gram-negative bacteria in the hospital setting and the role of elderly 
patients with bacterial bloodstream infection. Infection Control & Hospital 
Epidemiology, 30(4), 325-331. doi:10.1086/596608 
Rahmqvist, M., Samuelsson, A., Bastami, S., & Rutberg, H. (2016). Direct health care costs and 
length of hospital stay related to health care-acquired infections in adult patients based on 
point prevalence measurements. Am J Infect Control, 44(5), 500-506. 
doi:10.1016/j.ajic.2016.01.035 
Raman, G., Avendano, E., Berger, S., & Menon, V. (2015). Appropriate initial antibiotic therapy 
in hospitalized patients with gram-negative infections: systematic review and meta-
analysis. BMC Infect Dis, 15, 395. doi:10.1186/s12879-015-1123-5 
Rodriguez-Bano, J., Lopez-Prieto, M. D., Portillo, M. M., Retamar, P., Natera, C., Nuno, E., . . . 
Perez-Lopez, J. A. (2010). Epidemiology and clinical features of community-acquired, 
healthcare-associated and nosocomial bloodstream infections in tertiary-care and 
community hospitals. Clin Microbiol Infect, 16(9), 1408-1413. doi:10.1111/j.1469-
0691.2009.03089.x 
Rothstein HR , S. A., & Borenstein M,. (2005). Publication Bias in Meta-Analysis: Prevention, 
Assessment, and Adjustments. West Sussex, England: John Wiley & Sons, Ltd. 
  92 
Sadowska-Krawczenko, I., Jankowska, A., & Kurylak, A. (2012). Healthcare-associated 
infections in a neonatal intensive care unit. Arch Med Sci, 8(5), 854-858. 
doi:10.5114/aoms.2012.31412 
Sammon, J., Trinh, V. Q., Ravi, P., Sukumar, S., Gervais, M. K., Shariat, S. F., . . . Sun, M. 
(2013). Health care-associated infections after major cancer surgery: temporal trends, 
patterns of care, and effect on mortality. Cancer, 119(12), 2317-2324. 
doi:10.1002/cncr.28027 
Sogaard M, Norgaard M, Dethlefsen C, & Schonheyder HC. (2011). Temporal changes in the 
incidence and 30-day mortality associated with bacteremia in hospitalized patients from 
1992 through 2006: a population-based cohort study. Clin Infect Dis, 52(1), 61-69. 
doi:10.1093/cid/ciq069 
Southern, W. N., Berger, M. A., Bellin, E. Y., Hailpern, S. M., & Arnsten, J. H. (2007). 
Hospitalist care and length of stay in patients requiring complex discharge planning and 
close clinical monitoring. Archives of Internal Medicine, 167(17), 1869-1874. 
doi:10.1001/archinte.167.17.1869 
Spellberg, B., Blaser, M., Guidos, R. J., Boucher, H. W., Bradley, J. S., Eisenstein, B. I., . . . 
Gilbert, D. N. (2011). Combating antimicrobial resistance: policy recommendations to 
save lives. Clin Infect Dis, 52 Suppl 5, S397-428. doi:10.1093/cid/cir153 
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., . . . Edwards, 
J., Jr. (2008). The epidemic of antibiotic-resistant infections: a call to action for the 
medical community from the Infectious Diseases Society of America. Clin Infect Dis, 
46(2), 155-164. doi:10.1086/524891 
  93 
Stewart, J. H., Vajdic, C. M., van Leeuwen, M. T., Amin, J., Webster, A. C., Chapman, J. R., . . . 
McCredie, M. R. (2009). The pattern of excess cancer in dialysis and transplantation. 
Nephrol Dial Transplant, 24(10), 3225-3231. doi:10.1093/ndt/gfp331 
Stone, P. W. (2009). Economic burden of healthcare-associated infections: an American 
perspective. Expert Rev Pharmacoecon Outcomes Res, 9(5), 417-422. 
doi:10.1586/erp.09.53 
Strand, K., Walther, S. M., Reinikainen, M., Ala-Kokko, T., Nolin, T., Martner, J., . . . Flaatten, 
H. K. (2010). Variations in the length of stay of intensive care unit nonsurvivors in three 
Scandinavian countries. Crit Care, 14(5), R175. doi:10.1186/cc9279 
Stroup, D. F., Berlin, J. A., Morton, S. C., Olkin, I., Williamson, G. D., Rennie, D., . . . Thacker, 
S. B. (2000). Meta-analysis of observational studies in epidemiology: a proposal for 
reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. 
Jama, 283(15), 2008-2012.  
Sydnor, E. R., & Perl, T. M. (2011). Hospital epidemiology and infection control in acute-care 
settings. Clin Microbiol Rev, 24(1), 141-173. doi:10.1128/cmr.00027-10 
Thompson, S. G., & Higgins, J. P. (2002). How should meta-regression analyses be undertaken 
and interpreted? Stat Med, 21(11), 1559-1573. doi:10.1002/sim.1187 
Tsakiridou, E., Makris, D., Chatzipantazi, V., Vlachos, O., Xidopoulos, G., Charalampidou, O., . 
. . Zakynthinos, E. (2013). Diabetes and hemoglobin a1c as risk factors for nosocomial 
infections in critically ill patients. Crit Care Res Pract, 2013, 279479. 
doi:10.1155/2013/279479 
Tuon, F. F., Graf, M. E., Merlini, A., Rocha, J. L., Stallbaum, S., Arend, L. N., & Pecoit-Filho, 
R. (2017). Risk factors for mortality in patients with ventilator-associated pneumonia 
  94 
caused by carbapenem-resistant Enterobacteriaceae. Braz J Infect Dis, 21(1), 1-6. 
doi:10.1016/j.bjid.2016.09.008 
Usinger, K. M., Gola, S. B., Weis, M., & Smaldone, A. (2016). Intrauterine Contraception 
Continuation in Adolescents and Young Women: A Systematic Review. J Pediatr 
Adolesc Gynecol, 29(6), 659-667. doi:10.1016/j.jpag.2016.06.007 
Uslan, D. Z., Crane, S. J., Steckelberg, J. M., Cockerill, F. R., 3rd, St Sauver, J. L., Wilson, W. 
R., & Baddour, L. M. (2007). Age- and sex-associated trends in bloodstream infection: a 
population-based study in Olmsted County, Minnesota. Archives of Internal Medicine, 
167(8), 834-839.  
van Vught, L. A., Klein Klouwenberg, P. M., Spitoni, C., Scicluna, B. P., Wiewel, M. A., Horn, 
J., . . . van der Poll, T. (2016). Incidence, Risk Factors, and Attributable Mortality of 
Secondary Infections in the Intensive Care Unit After Admission for Sepsis. Jama, 
315(14), 1469-1479. doi:10.1001/jama.2016.2691 
Venkatachalam, I., Yang, H. L., Fisher, D., Lye, D. C., Moi Lin, L., Tambyah, P., & Perl, T. M. 
(2014). Multidrug-resistant gram-negative bloodstream infections among residents of 
long-term care facilities. Infection Control & Hospital Epidemiology, 35(5), 519-526. 
doi:10.1086/675823 
Verburg, I. W., de Keizer, N. F., de Jonge, E., & Peek, N. (2014). Comparison of regression 
methods for modeling intensive care length of stay. PLoS One, 9(10), e109684. 
doi:10.1371/journal.pone.0109684 
Vincitorio, D., Barbadoro, P., Pennacchietti, L., Pellegrini, I., David, S., Ponzio, E., & Prospero, 
E. (2014). Risk factors for catheter-associated urinary tract infection in Italian elderly. 
Am J Infect Control, 42(8), 898-901. doi:10.1016/j.ajic.2014.05.006 
  95 
Voskuijl, T., Hageman, M., & Ring, D. (2014). Higher Charlson Comorbidity Index Scores are 
associated with readmission after orthopaedic surgery. Clin Orthop Relat Res, 472(5), 
1638-1644. doi:10.1007/s11999-013-3394-8 
Wang, S. H., Hines, L., van Balen, J., Mediavilla, J. R., Pan, X., Hoet, A. E., . . . Stevenson, K. 
B. (2015). Molecular and clinical characteristics of hospital and community onset 
methicillin-resistant Staphylococcus aureus strains associated with bloodstream 
infections. J Clin Microbiol, 53(5), 1599-1608. doi:10.1128/jcm.03147-14 
Watson, W., & Kapur, S. (2011). Atopic dermatitis. Allergy Asthma Clin Immunol, 7 Suppl 1, 
S4. doi:10.1186/1710-1492-7-s1-s4 
Webster, P. (2017). Antibiotic overprescribing a growing problem. Cmaj, 189(5), E222. 
doi:10.1503/cmaj.1095383 
White House. (2015). National strategy for combating antibiotic resistant bacteria.   Retrieved 
from https://www.whitehouse.gov/sites/default/files/docs/carb_national_strategy.pdf 
World Health Organization. (2015). Antimicrobial resistance.   Retrieved from 
http://www.who.int/drugresistance/AMR_Importance/en/)  
Xu, Z. Q., Flavin, M. T., & Flavin, J. (2014). Combating multidrug-resistant Gram-negative 
bacterial infections. Expert Opin Investig Drugs, 23(2), 163-182. 
doi:10.1517/13543784.2014.848853 
Yang, C. J., Chung, Y. C., Chen, T. C., Chang, H. L., Tsai, Y. M., Huang, M. S., . . . Lu, P. L. 
(2013). The impact of inappropriate antibiotics on bacteremia patients in a community 
hospital in Taiwan: an emphasis on the impact of referral information for cases from a 
hospital affiliated nursing home. BMC Infect Dis, 13, 500. doi:10.1186/1471-2334-13-
500 
  96 
Zaky, A., Zeliadt, S. B., & Treggiari, M. M. (2015). Patient-level interventions to prevent the 
acquisition of resistant gram-negative bacteria in critically ill patients: a systematic 
review. Anaesth Intensive Care, 43(1), 23-33.  
Zimlichman, E., Henderson, D., Tamir, O., Franz, C., Song, P., Yamin, C. K., . . . Bates, D. W. 
(2013). Health care-associated infections: a meta-analysis of costs and financial impact 
on the US health care system. JAMA Intern Med, 173(22), 2039-2046. 
doi:10.1001/jamainternmed.2013.9763 
 
 
 
